Epidemiological and statistical research on health problems of developing countries: MRC Tropical Epidemiology Group

Lead Research Organisation: London School of Hygiene & Tropical Medicine
Department Name: Epidemiology and Population Health

Abstract

The past decade has seen significant progress in health in developing countries as well as setbacks and new challenges. Gains in health in many low-income countries have been reversed due to the global epidemic of HIV/AIDS and steep increases in tuberculosis (TB). Malaria remains a major killer of children in Africa despite declines in some countries. There is an urgent need to find effective means of controlling these major diseases.

The main aim of the MRC Tropical Epidemiology Group, based at the London School of Hygiene & Tropical Medicine, is to conduct research on interventions against diseases of major public health importance in Africa and other parts of the developing world. We collaborate with scientific groups overseas, including MRC Units in The Gambia and Uganda, assisting with the planning and analysis of research studies. These studies are designed to improve our understanding of risk factors for these diseases, and to evaluate the impact of different control measures. During the next five years, our main focus will continue to be on HIV, TB and malaria, and we will expand our work on non-communicable diseases, which are rapidly increasing in importance in developing countries.

There have been major advances in HIV prevention in recent years, especially around the potential for antiretroviral drugs to be used to prevent HIV transmission. We will work on further studies to evaluate methods of preventing and treating HIV infection, and to scale up interventions, such as voluntary medical male circumcision, that are known to reduce the risk of HIV infection. We will also expand work on integration of care for HIV-patients with treatment of other chronic diseases such as heart disease and diabetes. Research on human papillomavirus (HPV), which can cause cervical cancer, will include studies of how best to deliver HPV vaccination to girls and young women in sub-Saharan Africa.

Our TB research will focus on large-scale trials to assess how best to treat patients co-infected with both TB and HIV, and to improve the ways in which care for TB and HIV are integrated. A new diagnostic test for TB which has the potential to revolutionize TB diagnosis has recently been developed (Xpert MTB/RIF). We will also evaluate the impact and cost-effectiveness of this test for routine TB diagnosis in South Africa.

Substantial reductions in malaria have been reported recently, but much of this progress has been in countries with low levels of malaria, and malaria rates remain unacceptably high in many African countries. In the Sahel region, most of the malaria mortality and morbidity occurs during the short rainy season. We have been closely involved in research showing that giving effective malaria chemoprevention during this period prevents illness and death from malaria in children. We will continue our research in this area, including assessing the impact of this treatment strategy on malaria cases and deaths when delivered through routine health services. We will also continue research on promising malaria vaccines, and to evaluate new methods to control the mosquitoes that transmit malaria.

While the major infectious diseases continue to play a major role, especially in sub-Saharan Africa, there is increasing recognition of the impact of non-communicable diseases. The prevalence of conditions such as cardiovascular disease, diabetes and mental illness is increasing, especially in growing urban centres in developing countries, and will require innovative approaches to prevention and control.

There are few experienced medical statisticians in research institutions and universities in Africa, and an important aspect of our work is to support a fellowship scheme, which provides a two-year training programme for statisticians. In addition, we teach research methods at workshops at collaborating sites and provide informal mentoring and supervision to statisticians and epidemiologists we work with.

Technical Summary

We will conduct epidemiological research on HIV, TB, malaria and other diseases of public health importance in developing countries with an emphasis on randomised intervention trials.

In HIV, we will conduct the first trial of the impact of a test-and-treat intervention on HIV incidence in Africa, implementation research on scale-up of male circumcision, and RCTs to reduce early mortality among patients with low CD4 counts and to evaluate different treatment strategies for cryptococcal meningitis.

In TB, we will complete a trial of a four-month pulmonary TB treatment regimen. We will extend our research on treatment strategies for TB and HIV co-infection, including trials to compare 3 treatment strategies in ARV-naïve TB/HIV patients, a CRT to assess the effect of a point-of-care TB test-and-treat algorithm on early mortality in HIV-infected patients accessing ART; and a CRT of the impact of TB diagnosis by Xpert MTB/RIF on mortality and time-to-initiation of treatment.

Malaria research will build on previous work on Seasonal Malaria Chemoprevention (SMC), to evaluate effectiveness of delivery through routine health services, to monitor for adverse effects and to determine the effectiveness of adding SMC to existing control strategies for malaria. We will continue to evaluate multi-component malaria control on Bioko Island, and will develop new collaborations to assess the role of the RTS,S vaccine if licensed.

We will continue trials on lay-health worker interventions to treat common mental disorders, on the beneficial and adverse effects of helminths and antihelmintics on other conditions and of the effectiveness of pneumococcal vaccines. Methodological work will include spatial analysis of spill-over effects in CRTs, and evaluation and prediction of vaccine impact. Finally, we will continue to build research capacity in Africa, including development of the MRC-supported Mwanza Intervention Trials Unit and our programme of TEG training fellowships.

Planned Impact

As highlighted in the Millennium Development Goals, there is a strong synergy between ill-health and poverty. Our research focuses on diseases that are major causes of morbidity and mortality in resource-poor countries. These diseases have a substantial impact on the socio-economic development of many of these countries. By reducing the rates of important causes of ill health, such measures have the potential to alleviate poverty as well as improving life expectancy. We are expanding our focus on implementation research of proven interventions, and health systems research, which can improve the effectiveness and efficiency of health care delivery and ensure that resources reach the right people.

Many of the diseases we focus on typically affect the poorest in resource-poor countries, and those marginalised from society. We have a strong focus on community-based interventions (for example, in the PopART and TB trials which incorporate home-based HIV and TB testing) which help to overcome barriers to health service access and minimize stigma and discrimination. We also focus on scaling-up interventions which have been proven to be effective - for example male circumcision for HIV prevention, and seasonal malaria chemoprevention in areas with highly seasonal malaria transmission. This implementation research will help ensure access to effective prevention technologies for those who need it, regardless of socio-economic status. Our expanding health systems research (for example on integrating HIV and non-communicable disease treatment and care) will also increase the population-level impact of known effective treatment.

Our research is locally disseminated to study populations, and to regional and national stakeholders and policymakers, as appropriate. This includes providing information to enable policy-makers to make decisions about cost-effective strategies of roll-out (for example, for HPV vaccination or male circumcision scale-up), or access to new technology (such as TB diagnostics including Xpert MTB/RIF). We also play an active role in influencing global health policy and directions for future research, through membership of international technical and policy advisory committees including chairing the WHO Joint Technical Expert Group on Malaria Vaccines in Pivotal Phase 3 Trials & Beyond, the WHO Malaria Policy Advisory Committee Evidence Review Group on Malaria Burden Estimation and the EDCTP Partnership Board; and membership of several other Committees, as outlined in the Case for Support.

Organisations

Publications

10 25 50

publication icon
Ae-Ngibise KA (2015) Prevalence and risk factors for Active Convulsive Epilepsy in Kintampo, Ghana. in The Pan African medical journal

publication icon
Afolabi MO (2015) A multimedia consent tool for research participants in the Gambia: a randomized controlled trial. in Bulletin of the World Health Organization

publication icon
Agweyu A (2015) Oral amoxicillin versus benzyl penicillin for severe pneumonia among kenyan children: a pragmatic randomized controlled noninferiority trial. in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

publication icon
Agyepong I (2015) Making sense of health estimates. in Lancet (London, England)

 
Description Combining Indoor Residual Spraying and Insecticidal Long Lasting Nets: presentation to WHO Malaria Advisory Committee
Geographic Reach Africa 
Policy Influence Type Participation in a guidance/advisory committee
URL http://www.who.int/malaria/publications/atoz/who-guidance-combining-irs_llins-mar2014.pdf
 
Description Comment to European Medicine Agency on 'Questions and answers on Data Monitoring Committees issues' (EMA/492010/2018)
Geographic Reach Europe 
Policy Influence Type Contribution to a national consultation/review
 
Description Deployment of pyrethroid-PBO nets
Geographic Reach Multiple continents/international 
Policy Influence Type Citation in other policy documents
Impact Deployment of pyrethroid-PBO nets in areas where the main malaria vector(s) have pyrethroid resistance
URL http://apps.who.int/iris/bitstream/10665/258939/1/WHO-HTM-GMP-2017.17-eng.pdf?ua=1
 
Guideline Title Ebola Virus Disease (EVD) Information for Clinicians in U.S. Healthcare Settings
Description Ebola Clinical Management
Geographic Reach North America 
Policy Influence Type Citation in clinical guidelines
URL http://www.cdc.gov/vhf/ebola/healthcare-us/preparing/clinicians.html
 
Description HIV self-testing WHO prequalification
Geographic Reach Multiple continents/international 
Policy Influence Type Influenced training of practitioners or researchers
Impact Note that Oraquick was PQed in 2017 and INSTI in 2018 - one of the goals of the STAR project was to develop a market for HIV Self Testing approved by regulatory bodies. https://globenewswire.com/news-release/2018/11/28/1658183/0/en/INSTI-HIV-Self-Test-Earns-WHO-Prequalification-Status-for-Home-Testing.html and http://phx.corporate-ir.net/phoenix.zhtml?c=99740&p=irol-newsArticle_print&ID=2287929)
URL https://globenewswire.com/news-release/2018/11/28/1658183/0/en/INSTI-HIV-Self-Test-Earns-WHO-Prequal...
 
Description HIV services in Zambia and S Africa
Geographic Reach Africa 
Policy Influence Type Influenced training of practitioners or researchers
Impact Influenced training of practitioners or researchers delivering HIV services in Zambia and S Africa.
 
Description Membership of WHO Vector Control Advisory Group
Geographic Reach Multiple continents/international 
Policy Influence Type Membership of a guideline committee
URL http://www.who.int/neglected_diseases/vector_ecology/VCAG/en
 
Description REMSTART trial
Geographic Reach Multiple continents/international 
Policy Influence Type Citation in other policy documents
URL http://www.who.int/hiv/pub/guidelines/advanced-HIV-disease/en/
 
Description The Friendship Bench
Geographic Reach National 
Policy Influence Type Influenced training of practitioners or researchers
Impact A recently carried out randomized control trial showed that the Friendship Bench can deliver a successful, culturally acceptable and reliable treatment program for depression on a primary care level (Chibanda, D, Bowers, T, Verhey, R, Rusakaniko, S, Abas, M, Weiss, H A, Araya, R. The Friendship Bench programme: a cluster randomised controlled trial of a brief psychological intervention for common mental disorders delivered by lay health workers in Zimbabwe. International journal of mental health systems 2015a; 9, 21). It also addresses the stigma of mental illness in society, and the training of lay workers to deliver problem solving therapy helps address the deficit of mental health specialists in Zimbabwe.
URL http://www.friendshipbenchzimbabwe.org
 
Description WHO Vector Control Advisory Group
Geographic Reach Multiple continents/international 
Policy Influence Type Membership of a guideline committee
URL http://www.who.int/neglected_diseases/vector_ecology/VCAG/en/
 
Description A comparative trial of seasonal vaccination with the malaria vaccine RTS,S/AS01, seasonal malaria chemoprevention and the two interventions combined
Amount £3,491,906 (GBP)
Funding ID MR/P006876/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2016 
End 06/2020
 
Description ACCESS-SMC activities
Amount £308,900 (GBP)
Organisation Malaria Consortium Africa, Kampala 
Sector Charity/Non Profit
Country Uganda
Start 11/2017 
End 02/2019
 
Description Adolescent 360 Evaluation
Amount $479,341 (USD)
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 03/2016 
End 08/2021
 
Description Advances in approaches to optimise testing for sexually transmitted infections
Amount £36,552 (GBP)
Organisation Public Health England 
Sector Public
Country United Kingdom
Start 07/2018 
End 07/2019
 
Description Africa Centre Collaborations Fund
Amount £9,000 (GBP)
Funding ID ISSF/ADDE814710 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2014 
End 06/2015
 
Description AmBisone
Amount £10,677 (GBP)
Organisation Médecins Sans Frontières (MSF) 
Sector Charity/Non Profit
Country France
Start 08/2016 
End 03/2018
 
Description Aurum Institute - Highly TB exposed, persistently uninfected South African gold miners: HETU study
Amount $971,347 (USD)
Organisation Aurum Institute 
Sector Charity/Non Profit
Country South Africa
Start 11/2014 
End 12/2016
 
Description BMFG - China Gates
Amount $418,871 (USD)
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 11/2014 
End 09/2019
 
Description BMGF - Penn State Uni (Eave Tubes Trial)
Amount $938,000 (USD)
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 11/2015 
End 11/2018
 
Description CDC/Fiotec Zika project
Amount $184,000 (USD)
Organisation Centers for Disease Control and Prevention (CDC) 
Sector Public
Country United States
Start 04/2017 
End 08/2018
 
Description CHIDO Trial
Amount $54,941 (USD)
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe) 
Sector Charity/Non Profit
Country Zimbabwe
Start 01/2016 
End 12/2017
 
Description Challenge TB (WHIP3TB Aurum)
Amount $14,264,118 (USD)
Funding ID AID-OAA-A-14-00029 
Organisation United States Agency for International Development 
Sector Public
Country United States
Start 03/2016 
End 09/2019
 
Description Cluster randomized trial of the Zvandiri programme
Amount £36,578 (GBP)
Organisation Viiv Healthcare 
Sector Private
Country United Kingdom
Start 03/2017 
End 12/2018
 
Description Combined HIV African Prevention Study: On demand Truvada and F/TAF Pre-exposure and Post exposure prophylaxis to protect adolescents from HIV
Amount € 2,999,999 (EUR)
Funding ID RIA2016MC-1616 
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 03/2018 
End 03/2021
 
Description DIAMA
Amount € 2,967,202 (EUR)
Funding ID DRIA2014-326 
Organisation Sixth Framework Programme (FP6) 
Department European and Developing Countries Clinical Trials Partnership
Sector Public
Country Netherlands
Start 05/2016 
End 05/2021
 
Description DNDI Technical agreement (AfriCoLeish II)
Amount £37,000 (GBP)
Organisation Drugs for Neglected Diseases initiative (DNDi) 
Sector Charity/Non Profit
Country Switzerland
Start 03/2017 
End 03/2018
 
Description Data Collection & Analysis of the Zimbabwe & the Friendship Bench: Deployment of Services for Formative Efforts to Understand Mental Health Issues among HIV-infected Adolescents Project Research Findings
Amount $14,000 (USD)
Organisation United States President's Emergency Plan for AIDS Relief 
Sector Public
Country United States
Start 03/2017 
End 09/2018
 
Description EU FP7 Theme: AfriCoLeish
Amount € 3,000,000 (EUR)
Funding ID 305178 
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 01/2013 
End 12/2016
 
Description Effects of metronidazole plus intermittent preventive treatment of malaria in pregnancy on birth outcomes: a randomised controlled trial in Zambia.
Amount £2,496,504 (GBP)
Funding ID MR/S004998/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 11/2018 
End 10/2022
 
Description Electronic Data Capture to support rapid epidemiological research and vaccine trials during: Stage 2
Amount £539,143 (GBP)
Organisation National Institute for Health Research 
Sector Public
Country United Kingdom
Start 03/2018 
End 03/2020
 
Description Epidemiological and statistical research on health problems of low and middle-income countries: MRC Tropical Epidemiology Group (TEG)
Amount £4,128,086 (GBP)
Funding ID MR/R010161/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 11/2018 
End 10/2024
 
Description GSK Fellowships
Amount £184,050 (GBP)
Organisation GlaxoSmithKline (GSK) 
Sector Private
Country Global
Start 03/2018 
End 08/2022
 
Description INTREPID II
Amount £279,812 (GBP)
Funding ID MR/P025927/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2017 
End 09/2022
 
Description Investigation of HEV transmission dynamics and epidemic evolution to improve outbreak control efforts among emergency affected populations
Amount $11,687 (USD)
Organisation CDC Foundation 
Sector Public
Country United States
Start 12/2015 
End 12/2016
 
Description Joint Global Health Trials
Amount £2,986,615 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2016 
End 02/2021
 
Description Joint Global Health Trials (MENISCUS-2)
Amount £203,351 (GBP)
Funding ID MR/P020283/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2017 
End 12/2018
 
Description Joint Global Health Trials 2013
Amount £836,321 (GBP)
Funding ID MR/L00433X/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 12/2013 
End 05/2016
 
Description Joint Global Health Trials 2013
Amount £1,856,394 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2014 
End 09/2017
 
Description Joint Global Health Trials Development Grant
Amount £200,000 (GBP)
Funding ID MR/P020283/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2017 
End 10/2018
 
Description MRC Adolescent Health Call (Friendship Bench)
Amount £560,269 (GBP)
Funding ID MR/P012485/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 03/2017 
End 12/2018
 
Description MSF - TB PRACTECAL
Amount £542,440 (GBP)
Organisation Médecins Sans Frontières (MSF) 
Sector Charity/Non Profit
Country France
Start 09/2013 
End 12/2022
 
Description MSF SAM Trial
Amount £32,600 (GBP)
Organisation Médecins Sans Frontières (MSF) 
Sector Charity/Non Profit
Country France
Start 12/2017 
End 12/2019
 
Description Mass drug administration of ivermectin and dihydroartemisinin-piperaquine as an additional intervention for malaria elimination
Amount £2,057,637 (GBP)
Funding ID MC_EX_MR/R006075/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 08/2017 
End 01/2021
 
Description Master's Fellowship in Epidemiology and Medical Statistics
Amount £119,985 (GBP)
Organisation Sixth Framework Programme (FP6) 
Department European and Developing Countries Clinical Trials Partnership
Sector Public
Country Netherlands
Start 08/2014 
End 09/2016
 
Description Master's Fellowship in Epidemiology and Medical Statistics
Amount £119,985 (GBP)
Organisation Sixth Framework Programme (FP6) 
Department European and Developing Countries Clinical Trials Partnership
Sector Public
Country Netherlands
Start 09/2014 
End 09/2016
 
Description Master's Fellowship in Epidemiology and Medical Statistics
Amount £116,925 (GBP)
Organisation Sixth Framework Programme (FP6) 
Department European and Developing Countries Clinical Trials Partnership
Sector Public
Country Netherlands
Start 08/2014 
End 09/2016
 
Description New Investigator Research Grant - Suzanna Francis
Amount £917,566 (GBP)
Funding ID MR/N023692/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 06/2016 
End 06/2019
 
Description Newton Household Screening for TB
Amount £57,297 (GBP)
Organisation Medical Research Council of South Africa (MRC) 
Sector Public
Country South Africa
Start 04/2016 
End 12/2018
 
Description PRIDE (PRemIum for aDolEscents).
Amount £3,715,770 (GBP)
Funding ID 106919/A/15/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 03/2017 
End 10/2022
 
Description Public Health Intervention Development Scheme
Amount £150,000 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 09/2014 
End 07/2015
 
Description Public Health Intervention Development Scheme
Amount £143,663 (GBP)
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 02/2014 
End 10/2014
 
Description RAFAScreen
Amount € 39,856 (EUR)
Organisation National Tuberculosis Programme of Benin 
Sector Public
Country Benin
Start 07/2015 
End 07/2016
 
Description RIFASHORT (Joint funded initiatives)
Amount £2,595,670 (GBP)
Funding ID MR/M006127/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 05/2016 
End 12/2019
 
Description Research & Innovation Action
Amount € 41,385 (EUR)
Funding ID 666094 
Organisation European Commission 
Sector Public
Country European Union (EU)
Start 11/2014 
End 10/2015
 
Description Strengthening Capacity to improve Adolescent Health & Wellbeing in Southern Africa
Amount £134,688 (GBP)
Organisation Viiv Healthcare 
Sector Private
Country United Kingdom
Start 07/2018 
End 07/2020
 
Description Strengthening East and Southern African capacity for menstrual hygiene management (MHM) research
Amount £24,767 (GBP)
Organisation Academy of Medical Sciences (AMS) 
Sector Charity/Non Profit
Country United Kingdom
Start 08/2018 
End 08/2019
 
Description TE NTD Research for Sightsavers
Amount £91,236 (GBP)
Organisation Sightsavers 
Sector Charity/Non Profit
Country Global
Start 12/2014 
End 12/2015
 
Description Technical Support for Insecticide Resistance in India
Amount $63,887 (USD)
Funding ID 39312 
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 12/2015 
End 12/2016
 
Description Tuberculosis: Innovative Delivery Approaches
Amount $203,358 (USD)
Organisation Bill and Melinda Gates Foundation 
Sector Charity/Non Profit
Country United States
Start 11/2014 
End 10/2016
 
Description UNITAID Strategic Objective 4: Treatment of Malaria (Round 2)
Amount $67,400,000 (USD)
Organisation World Health Organization (WHO) 
Department UNITAID
Sector Public
Country Switzerland
Start 01/2015 
End 12/2018
 
Description UNITAID Strategic Objective 6: Preventatives for HIV/Aids, TB and Malaria
Amount $7,480,000 (USD)
Organisation World Health Organization (WHO) 
Department UNITAID
Sector Public
Country Switzerland
Start 01/2015 
End 12/2018
 
Description UNITAID/PSI STAR Project
Amount $244,169 (USD)
Organisation World Health Organization (WHO) 
Department UNITAID
Sector Public
Country Switzerland
Start 09/2015 
End 10/2017
 
Description WT Senior Research Fellowship for Eugene Kinyanda
Amount £2,021,099 (GBP)
Funding ID 205069/Z/16/Z 
Organisation Wellcome Trust 
Sector Charity/Non Profit
Country United Kingdom
Start 02/2017 
End 03/2022
 
Description What is the sensitivity, specificity, and unintended consequences of a trial of (nonTB) antibiotics
Amount £68,580 (GBP)
Organisation University of Malawi 
Sector Academic/University
Country Malawi
Start 08/2017 
End 08/2020
 
Description YATHU YATHU ("For us by us"): A Cluster Randomised Trial of community-based SRH and HIV services for adolescents and young people in Zambia
Amount £2,183,245 (GBP)
Funding ID MR/R022216/1 
Organisation Medical Research Council (MRC) 
Sector Public
Country United Kingdom
Start 06/2018 
End 06/2022
 
Description Zero TB Baseline & Endline Survey (IRD Pakistan)
Amount $76,124 (USD)
Organisation Global Fund to Fight AIDS, Tuberculosis and Malaria 
Sector Charity/Non Profit
Country Switzerland
Start 03/2017 
End 12/2017
 
Description Zvandiri Project
Amount £43,147 (GBP)
Organisation Viiv Healthcare 
Sector Private
Country United Kingdom
Start 01/2016 
End 12/2016
 
Title Statistical methods for stepped wedge trials 
Description Developing appropriate methods of analysis for use in stepped wedge trials 
Type Of Material Improvements to research infrastructure 
Year Produced 2018 
Provided To Others? Yes  
Impact Adoption of new more appropriate statistical methods that reflect the true uncertainty of trial results 
 
Title ART and HPV 
Description Data from a systematic review on ART and HPV infection 
Type Of Material Database/Collection of data 
Year Produced 2017 
Provided To Others? Yes  
Impact None yet 
URL http://datacompass.lshtm.ac.uk
 
Title Data for Thinking Healthy Programme India trial (THPP-India) 
Description An anonymised dataset of 280 women (one row per woman) who gave informed consent to participate in an individually-randomised, parallel, superiority, controlled trial in Goa, India in 2014-2016. The intervention was an adapted version of the Thinking Healthy Programme, delivered by peers; the control was enhanced usual care. Further details are available in the published protocol and paper. The dataset contains records of variables on stratified randomisation, socio-demographic information, depression and related outcomes, and therapy adherence. Visits occurred at baseline, and 3 and 6 months post-natal. 
Type Of Material Database/Collection of data 
Year Produced 2018 
Provided To Others? Yes  
Impact none yet 
URL http://datacompass.lshtm.ac.uk/id/eprint/793
 
Title Data for Thinking Healthy Programme Pakistan trial (THPP-Pakistan) 
Description An anonymised dataset of 570 women (one row per woman) who gave informed consent to participate in a cluster randomised, parallel, superiority, controlled trial in Rawalpindi, Pakistan in 2014-2017. The intervention was an adapted version of the Thinking Healthy Programme, delivered by peers; the control was enhanced usual care. Further details are available in the published protocol and paper. The dataset contains records of variables on stratified randomisation and clusters, socio-demographic information, depression and related outcomes, and therapy adherence. Visits occurred at baseline, and 3 and 6 months post-natal. 
Type Of Material Database/Collection of data 
Year Produced 2018 
Provided To Others? Yes  
Impact None yet 
URL http://datacompass.lshtm.ac.uk/id/eprint/794
 
Title HC-HIV IPD dataset 
Description The HC-HIV IPD database 18 HIV prevention studies, including 37,124 women (43,613 woman-years) and 1,830 incident HIV infections 
Type Of Material Database/Collection of data 
Year Produced 2017 
Provided To Others? Yes  
Impact Impact on WHO policy for contraception 
 
Title PREMIUM twelve-month follow-up trial: Clinical Outcomes and Cost-effectiveness dataset from the Counselling for Alcohol Problems (CAP) RCT 
Description Datasets for the two PREMIUM trials 
Type Of Material Database/Collection of data 
Year Produced 2017 
Provided To Others? Yes  
Impact None yet 
URL http://datacompass.lshtm.ac.uk/514/
 
Title PREMIUM twelve-month follow-up trial: Clinical Outcomes and Cost-effectiveness dataset from the Healthy Activity Program (HAP) RCT 
Description Datasets for the two PREMIUM trials 
Type Of Material Database/Collection of data 
Year Produced 2017 
Provided To Others? Yes  
Impact None yet 
URL http://datacompass.lshtm.ac.uk/513/
 
Title STIMA Dataset 
Description Revised database from HC-HIV database that included 18 HIV prevention studies (cohort studies and randomized controlled trials; conducted during 1993±2011), representing >37,000 women, that tested participants for >1 selected STIs or BV at baseline 
Type Of Material Database/Collection of data 
Year Produced 2017 
Provided To Others? Yes  
Impact None yet 
 
Title VMB Dataset 
Description Combined data from 16SrRNA sequencing, NMR metabolomic and 33 immune protein targets from 221 women 
Type Of Material Database/Collection of data 
Year Produced 2017 
Provided To Others? No  
Impact None yet 
 
Description 3HPstudy 
Organisation Aurum Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Study design and analysis
Collaborator Contribution Study design, co-ordination, economic modelling, trial recruitment
Impact Multi-disciplinary: public health, health economics, statistics, trial design
Start Year 2015
 
Description 3HPstudy 
Organisation Johns Hopkins University
Country United States 
Sector Academic/University 
PI Contribution Study design and analysis
Collaborator Contribution Study design, co-ordination, economic modelling, trial recruitment
Impact Multi-disciplinary: public health, health economics, statistics, trial design
Start Year 2015
 
Description ALERRT 
Organisation University of Oxford
Country United Kingdom 
Sector Academic/University 
PI Contribution study design & analysis
Collaborator Contribution study design & analysis, collaborator meetings
Impact Multi-disciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2018
 
Description AMARI 
Organisation Addis Ababa University
Country Ethiopia 
Sector Academic/University 
PI Contribution Steering committee member
Collaborator Contribution Study co-ordination
Impact PhD and post-doctoral researchers enrolled
Start Year 2015
 
Description AMARI 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution Steering committee member
Collaborator Contribution Study co-ordination
Impact PhD and post-doctoral researchers enrolled
Start Year 2015
 
Description AMARI 
Organisation University of Malawi
Country Malawi 
Sector Academic/University 
PI Contribution Steering committee member
Collaborator Contribution Study co-ordination
Impact PhD and post-doctoral researchers enrolled
Start Year 2015
 
Description AMARI 
Organisation University of Zimbabwe
Country Zimbabwe 
Sector Academic/University 
PI Contribution Steering committee member
Collaborator Contribution Study co-ordination
Impact PhD and post-doctoral researchers enrolled
Start Year 2015
 
Description AZ-SMC trial 
Organisation National Center for Scientific and Technological Research (CNRST)
Department Institute of Research in Health Sciences
Country Burkina Faso 
Sector Public 
PI Contribution Study design, analysis
Collaborator Contribution Clinical, field, lab studies
Impact NEJM paper (DOI: 10.1056/NEJMoa1811400) Multidisciplinary: epidemiology, statistics, clinical trials Informed WHO guidelines on AZ deployment (still in development)
Start Year 2014
 
Description AZ-SMC trial 
Organisation University of Bamako
Department Malaria Research and Training Centre (MRTC) Bamako
Country Mali 
Sector Academic/University 
PI Contribution Study design, analysis
Collaborator Contribution Clinical, field, lab studies
Impact NEJM paper (DOI: 10.1056/NEJMoa1811400) Multidisciplinary: epidemiology, statistics, clinical trials Informed WHO guidelines on AZ deployment (still in development)
Start Year 2014
 
Description Adolescents 360 
Organisation Avenir Health
Country United States 
Sector Private 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact Multi-disciplinary: qualitative research, health economics, epidemiology. Four papers published, two papers in preparation, 3 conference presentations.
Start Year 2016
 
Description Adolescents 360 
Organisation Avenir Health
Country United States 
Sector Private 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact One paper submitted, two are in preparation. Disciplines include qualitative research, health economics, epidemiology
Start Year 2016
 
Description Adolescents 360 
Organisation BOL NIGERIA ! Bclems Outsourcing Limited
Sector Private 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact Multi-disciplinary: qualitative research, health economics, epidemiology. Four papers published, two papers in preparation, 3 conference presentations.
Start Year 2016
 
Description Adolescents 360 
Organisation Itad Ltd
Country United Kingdom 
Sector Private 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact Multi-disciplinary: qualitative research, health economics, epidemiology. Four papers published, two papers in preparation, 3 conference presentations.
Start Year 2016
 
Description Adolescents 360 
Organisation Itad Ltd
Country United Kingdom 
Sector Private 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact One paper submitted, two are in preparation. Disciplines include qualitative research, health economics, epidemiology
Start Year 2016
 
Description Adolescents 360 
Organisation National Institute for Medical Research, Tanzania
Department Mwanza Intervention Trials Unit (MITU)
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact Multi-disciplinary: qualitative research, health economics, epidemiology. Four papers published, two papers in preparation, 3 conference presentations.
Start Year 2016
 
Description Adolescents 360 
Organisation National Institute for Medical Research, Tanzania
Department Mwanza Intervention Trials Unit (MITU)
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Principle investigator at LSHTM, study design, analysis
Collaborator Contribution Project management, process evaluation, cost analysis, liaison with implementers
Impact One paper submitted, two are in preparation. Disciplines include qualitative research, health economics, epidemiology
Start Year 2016
 
Description AfricoLeisch Consortium 
Organisation Drugs for Neglected Diseases initiative (DNDi)
Country Switzerland 
Sector Charity/Non Profit 
PI Contribution Statistical lead and data management oversight
Collaborator Contribution Intellectual input and expertise; access to data; capacity building; research dissemination
Impact Treatment trials in progress
Start Year 2013
 
Description AfricoLeisch Consortium 
Organisation European Commission
Country European Union (EU) 
Sector Public 
PI Contribution Statistical lead and data management oversight
Collaborator Contribution Intellectual input and expertise; access to data; capacity building; research dissemination
Impact Treatment trials in progress
Start Year 2013
 
Description AfricoLeisch Consortium 
Organisation Institute of Tropical Medicine Antwerp
Country Belgium 
Sector Academic/University 
PI Contribution Statistical lead and data management oversight
Collaborator Contribution Intellectual input and expertise; access to data; capacity building; research dissemination
Impact Treatment trials in progress
Start Year 2013
 
Description AfricoLeisch Consortium 
Organisation Médecins Sans Frontières (MSF)
Country France 
Sector Charity/Non Profit 
PI Contribution Statistical lead and data management oversight
Collaborator Contribution Intellectual input and expertise; access to data; capacity building; research dissemination
Impact Treatment trials in progress
Start Year 2013
 
Description AfricoLeisch Consortium 
Organisation University of Gondar
Country Ethiopia 
Sector Academic/University 
PI Contribution Statistical lead and data management oversight
Collaborator Contribution Intellectual input and expertise; access to data; capacity building; research dissemination
Impact Treatment trials in progress
Start Year 2013
 
Description AfricoLeisch Consortium 
Organisation University of Khartoum
Country Sudan 
Sector Academic/University 
PI Contribution Statistical lead and data management oversight
Collaborator Contribution Intellectual input and expertise; access to data; capacity building; research dissemination
Impact Treatment trials in progress
Start Year 2013
 
Description Assessing the impact of the introduction of pneumococcal conjugate vaccine into the childhood vaccine programme 
Organisation Wellcome Trust
Department KEMRI-Wellcome Trust Research Programme
Country Kenya 
Sector Academic/University 
PI Contribution Providing statistical support
Collaborator Contribution Principal investiagors and data collection
Impact Paper on efficacy of different pneumococcal conjugate vaccine schedules against pneumonia, hospitalisation, and mortality in the Gambia published in Vaccine (2014)
Start Year 2014
 
Description Associations between latent TB infection in mothers and infant immune response to immunisations 
Organisation University of Malawi
Country Malawi 
Sector Academic/University 
PI Contribution Statistical contribution to trial design. We will be supervising data analysis going forward.
Collaborator Contribution Significant intellectual input and mutual exchange of ideas
Impact None yet.
Start Year 2014
 
Description B-GAP 
Organisation Biomedical Research and Training Institute (BRTI)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Study design and analysis
Collaborator Contribution study design; coordination; field work; economic modelling;
Impact None yet.
Start Year 2017
 
Description CADDE (UK-Brazil) 
Organisation University of Oxford
Country United Kingdom 
Sector Academic/University 
PI Contribution Study design and analysis
Collaborator Contribution As previous, plus field and lab work.
Impact Multi-disciplinary: epidemiology, ecology, entomology, virology, GIS, statistics, public health.
Start Year 2018
 
Description CHIDO trial 
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2015
 
Description CHIEDZA 
Organisation Biomedical Research and Training Institute (BRTI)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Study design and analysis
Collaborator Contribution study design; coordination; field work; economic modelling;
Impact No outputs as yet. Collaboration is multi disciplinary including clinical trials, epidemiology, public health, statistics.
Start Year 2016
 
Description CMV immunology 
Organisation University of Oxford
Department Nuffield Department of Experimental Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution statistical analysis
Collaborator Contribution data collection, lab analysis
Impact paper in Clinical Infectious Diseases, 2 others being written, Multi-disciplinary: immunogenetics, epidemiology
Start Year 2017
 
Description COSTOP trial 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Design, implementation, analysis, interpret
Collaborator Contribution Design, implementation, analysis, interpret
Impact Seven papers; 1 oral presentation at CROI 2015 Multidisciplinary: Clinical medicine, epidemiology, qualitative research
Start Year 2010
 
Description CRT - creation strategies to increase voluntary medical male circumcision uptake in Zimbabwe 
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Statistical support
Collaborator Contribution Study coordination
Impact Multi-disciplinary: Epidemiology, economics, qualitative
Start Year 2018
 
Description CRT - creation strategies to increase voluntary medical male circumcision uptake in Zimbabwe 
Organisation Zimbabwe Population Services International (PSI)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Statistical support
Collaborator Contribution Study coordination
Impact Multi-disciplinary: Epidemiology, economics, qualitative
Start Year 2018
 
Description CRT of an intensified TB/HIV prevention intervention in Malawi 
Organisation Wellcome Trust
Department Malawi-Liverpool Wellcome Trust Clinical Research Programme
Country Malawi 
Sector Academic/University 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Trial leadership and all other aspects
Impact Intervention evaluation period is complete and final survey (HIV prevalence) is underway. Trial analysis is ongoing. Paper on a sub-trial of home-based versus community-based initiation of HIV care published in JAMA (2014).
Start Year 2010
 
Description CRT of intensive versus standard anthelminthic treatment and effects on allergy-related health outcomes 
Organisation Medical Research Council (MRC)
Department MRC/UVRI and LSHTM Research Unit Uganda
Country Uganda 
Sector Academic/University 
PI Contribution Contributed to trial design. Currently leading statistical analysis
Collaborator Contribution Trial leadership and all other aspects
Impact Protocol paper submitted to Trials, baseline findings presented at the European Academy of Allergy and Clinical Immunology (EAACI) conference in June 2014. Intervention is currently ongoing.
Start Year 2011
 
Description Clinical Trial: HIV combination prevention (PopArt) 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Chief Investigator; Trial design; Protocol development; Trial Statistician; Supervision; Administration
Collaborator Contribution Trial is carried out in partnership with NIH HIV Prevention Trials Network; Trial management, laboratory activities and data management and analysis supported by HPTN Core, Network Laboratory and Data and Statistics Center; Field work coordinated at Zambart and DTTC; Modelling and economics components coordinated by Imperial College.
Impact Funding for trial secured, research group established, protocol version 1.0 approved, IRB submissions
Start Year 2011
 
Description Clinical Trial: HIV combination prevention (PopArt) 
Organisation National Institutes of Health (NIH)
Department HIV Prevention Trials Network HPTN
Country United States 
Sector Charity/Non Profit 
PI Contribution Chief Investigator; Trial design; Protocol development; Trial Statistician; Supervision; Administration
Collaborator Contribution Trial is carried out in partnership with NIH HIV Prevention Trials Network; Trial management, laboratory activities and data management and analysis supported by HPTN Core, Network Laboratory and Data and Statistics Center; Field work coordinated at Zambart and DTTC; Modelling and economics components coordinated by Imperial College.
Impact Funding for trial secured, research group established, protocol version 1.0 approved, IRB submissions
Start Year 2011
 
Description Clinical Trial: HIV combination prevention (PopArt) 
Organisation University of Stellenbosch
Department Desmond Tutu TB Centre
Country South Africa 
Sector Academic/University 
PI Contribution Chief Investigator; Trial design; Protocol development; Trial Statistician; Supervision; Administration
Collaborator Contribution Trial is carried out in partnership with NIH HIV Prevention Trials Network; Trial management, laboratory activities and data management and analysis supported by HPTN Core, Network Laboratory and Data and Statistics Center; Field work coordinated at Zambart and DTTC; Modelling and economics components coordinated by Imperial College.
Impact Funding for trial secured, research group established, protocol version 1.0 approved, IRB submissions
Start Year 2011
 
Description Clinical Trial: HIV combination prevention (PopArt) 
Organisation Zambia AIDS Related Tuberculosis
Country Zambia 
Sector Academic/University 
PI Contribution Chief Investigator; Trial design; Protocol development; Trial Statistician; Supervision; Administration
Collaborator Contribution Trial is carried out in partnership with NIH HIV Prevention Trials Network; Trial management, laboratory activities and data management and analysis supported by HPTN Core, Network Laboratory and Data and Statistics Center; Field work coordinated at Zambart and DTTC; Modelling and economics components coordinated by Imperial College.
Impact Funding for trial secured, research group established, protocol version 1.0 approved, IRB submissions
Start Year 2011
 
Description Clinical Trial: TB Fast Track: a cluster randomised trial to evaluate the effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART 
Organisation Aurum Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. Recruitment to end in Dec 2014. Symposium at the Union TB conference in Barcelona 2014 on empiric TB treatment organised by TB Fast Track investigators
Start Year 2012
 
Description Clinical Trial: TB Fast Track: a cluster randomised trial to evaluate the effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART 
Organisation Foundation for Professional Development
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. Recruitment to end in Dec 2014. Symposium at the Union TB conference in Barcelona 2014 on empiric TB treatment organised by TB Fast Track investigators
Start Year 2012
 
Description Clinical Trial: TB Fast Track: a cluster randomised trial to evaluate the effect of a point-of-care TB test-and-treat algorithm on early mortality in people with HIV accessing ART 
Organisation Johns Hopkins University
Country United States 
Sector Academic/University 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. Recruitment to end in Dec 2014. Symposium at the Union TB conference in Barcelona 2014 on empiric TB treatment organised by TB Fast Track investigators
Start Year 2012
 
Description Clinical trial: Impact of helminths on the response to immunisation and on incidence of infection and disease in childhood 
Organisation Entebbe District Hospital
Country Uganda 
Sector Hospitals 
PI Contribution Designed and supported randomised trial evaluating 3 interventions at 2 stages.
Collaborator Contribution Trial leadership; Access to study cohort
Impact Trial found that anthelminthic treatment during pregnancy increased incidence of eczema in childhood, and that quarterly anthelminthic treatment during early childhood decreased the incidence of malaria. Apart from this, there were no other effects of anthelminthic treatment during pregnancy and childhood on responses to immunisations, incidence of infectious diseases, growth or anaemia. Main trial results have been published in the Lancet and in PLoS ONE. Children are now being follow-up to 10 years old.
Start Year 2006
 
Description Clinical trial: Impact of helminths on the response to immunisation and on incidence of infection and disease in childhood 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Designed and supported randomised trial evaluating 3 interventions at 2 stages.
Collaborator Contribution Trial leadership; Access to study cohort
Impact Trial found that anthelminthic treatment during pregnancy increased incidence of eczema in childhood, and that quarterly anthelminthic treatment during early childhood decreased the incidence of malaria. Apart from this, there were no other effects of anthelminthic treatment during pregnancy and childhood on responses to immunisations, incidence of infectious diseases, growth or anaemia. Main trial results have been published in the Lancet and in PLoS ONE. Children are now being follow-up to 10 years old.
Start Year 2006
 
Description Clinical trial: Implementation and evaluation of an optimized model for scaling up TB/HIV integration at primary care clinics in Ekurhuleni north sub-district, South Africa 
Organisation Aurum Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Protocol and CRFs drafted; trial completed and data currently being analysed. Paper published on trial design (Contemporary Clinical Trials 2014)
Start Year 2011
 
Description Clinical trial: Xpert MTB/RIF for diagnosis of tuberculosis: evaluating impact and cost-effectiveness in the routine roll-out in South Africa "Xpert for TB: Evaluating a New Diagnostic" (XTEND) trial and XPHACTOR study 
Organisation Aurum Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. XTEND trial completed and results presented at CROI (2014) and South Africa TB conference (2014). Main paper under review and other papers in progress. XPHACTOR recruitment and follow-up completed, data currently being analysed. Interim data presented at South Africa TB (2014) and Union TB Conference (2014); Papers in progress.
Start Year 2011
 
Description Clinical trial: Xpert MTB/RIF for diagnosis of tuberculosis: evaluating impact and cost-effectiveness in the routine roll-out in South Africa "Xpert for TB: Evaluating a New Diagnostic" (XTEND) trial and XPHACTOR study 
Organisation National Health Laboratory Services, South Africa
Country South Africa 
Sector Public 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. XTEND trial completed and results presented at CROI (2014) and South Africa TB conference (2014). Main paper under review and other papers in progress. XPHACTOR recruitment and follow-up completed, data currently being analysed. Interim data presented at South Africa TB (2014) and Union TB Conference (2014); Papers in progress.
Start Year 2011
 
Description Clinical trial: Xpert MTB/RIF for diagnosis of tuberculosis: evaluating impact and cost-effectiveness in the routine roll-out in South Africa "Xpert for TB: Evaluating a New Diagnostic" (XTEND) trial and XPHACTOR study 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. XTEND trial completed and results presented at CROI (2014) and South Africa TB conference (2014). Main paper under review and other papers in progress. XPHACTOR recruitment and follow-up completed, data currently being analysed. Interim data presented at South Africa TB (2014) and Union TB Conference (2014); Papers in progress.
Start Year 2011
 
Description Clinical trial: Xpert MTB/RIF for diagnosis of tuberculosis: evaluating impact and cost-effectiveness in the routine roll-out in South Africa "Xpert for TB: Evaluating a New Diagnostic" (XTEND) trial and XPHACTOR study 
Organisation World Health Organization (WHO)
Country Global 
Sector Public 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Funding for trial secured; research group established; protocol and CRFs drafted; trial started. XTEND trial completed and results presented at CROI (2014) and South Africa TB conference (2014). Main paper under review and other papers in progress. XPHACTOR recruitment and follow-up completed, data currently being analysed. Interim data presented at South Africa TB (2014) and Union TB Conference (2014); Papers in progress.
Start Year 2011
 
Description Collaborative group on the impact of digital technologies on TB 
Organisation World Health Organization (WHO)
Country Global 
Sector Public 
PI Contribution Contributed to a paper titled "Digital health technologies for active TB treatment support: A cost-effectiveness analysis" as part of the collaborative group, led by WHO
Collaborator Contribution WHO lead the collaborative group
Impact One publication submitted to a journal
Start Year 2017
 
Description Combined HIV Adolescent PrEP and Prevention Study 
Organisation Wits Health Consortium
Country South Africa 
Sector Private 
PI Contribution Study design, sample size, statistical analysis
Collaborator Contribution Laboratory analysis, field work, data collection, study design, scientific hypothesis
Impact Poster presented at HIVR4P, Oct 2018: http://apps.webofknowledge.com/InboundService.do?customersID=LinksAMR&mode=FullRecord&IsProductCode=Yes?uct=WOS&Init=Yes&Func=Frame&DestFail=http%3A%2F%2Fwww.webofknowledge.com?tion=retrieve&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&SID=C2bwzliNPISkWLdNkIt&UT=WOS%3A000448371600674 Multi-disciplinary: Epidemiology, social science, clinical trial, laboratory
Start Year 2018
 
Description DIAMA 
Organisation National Hospital of Pneumo-Phtisiology
Country Benin 
Sector Hospitals 
PI Contribution LSHTM lead on statistical analysis, contribution to data management and paper writing
Collaborator Contribution Coordination, study design, implementation, paper writing
Impact None yet
Start Year 2016
 
Description DIVIDS study and follow-ups 
Organisation University of Delhi
Department Institute of Home Economics
Country India 
Sector Academic/University 
PI Contribution Analysis of RCT of vitamin D supplementation to low birth weight term infants. Analysis of follow-up data from 4-5 year olds
Collaborator Contribution Co-ordination of the field work
Impact Analysis of main trial result in BMJ. Follow-up data was published in Int J Epi and BMJ Open. Multi-disciplinary - nutrition.
Start Year 2010
 
Description DREAMS evaluation 
Organisation African Population and Health Research Center
Country Kenya 
Sector Academic/University 
PI Contribution co-Principal investigator
Collaborator Contribution Co-design of impact evaluation design, new research questionnaires, lead responsibility for field implementation
Impact Presentations (oral and poster) at AIDS Impact conference 2017 and R4P 2018. Plos One journal supplement with papers reporting historical trends and baseline findings. Protocol paper published. Multi-disciplinary: Epidemiology, Demography, Public Health, Social Science
Start Year 2016
 
Description DREAMS evaluation 
Organisation Armauer Hansen Research Institute
Country Ethiopia 
Sector Charity/Non Profit 
PI Contribution co-Principal investigator
Collaborator Contribution Co-design of impact evaluation design, new research questionnaires, lead responsibility for field implementation
Impact Presentations (oral and poster) at AIDS Impact conference 2017 and R4P 2018. Plos One journal supplement with papers reporting historical trends and baseline findings. Protocol paper published. Multi-disciplinary: Epidemiology, Demography, Public Health, Social Science
Start Year 2016
 
Description DREAMS evaluation 
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution co-Principal investigator
Collaborator Contribution Co-design of impact evaluation design, new research questionnaires, lead responsibility for field implementation
Impact Presentations (oral and poster) at AIDS Impact conference 2017 and R4P 2018. Plos One journal supplement with papers reporting historical trends and baseline findings. Protocol paper published. Multi-disciplinary: Epidemiology, Demography, Public Health, Social Science
Start Year 2016
 
Description DREAMS evaluation 
Organisation Kenyan Institute for Medical Research (KEMRI)
Country Kenya 
Sector Public 
PI Contribution co-Principal investigator
Collaborator Contribution Co-design of impact evaluation design, new research questionnaires, lead responsibility for field implementation
Impact Presentations (oral and poster) at AIDS Impact conference 2017 and R4P 2018. Plos One journal supplement with papers reporting historical trends and baseline findings. Protocol paper published. Multi-disciplinary: Epidemiology, Demography, Public Health, Social Science
Start Year 2016
 
Description DREAMS evaluation 
Organisation United States President's Emergency Plan for AIDS Relief
Country United States 
Sector Public 
PI Contribution co-Principal investigator
Collaborator Contribution Co-design of impact evaluation design, new research questionnaires, lead responsibility for field implementation
Impact Presentations (oral and poster) at AIDS Impact conference 2017 and R4P 2018. Plos One journal supplement with papers reporting historical trends and baseline findings. Protocol paper published. Multi-disciplinary: Epidemiology, Demography, Public Health, Social Science
Start Year 2016
 
Description Dengue Index 
Organisation Khon Kaen University
Country Thailand 
Sector Academic/University 
PI Contribution Design and analysis of case-control study and cluster-randomized trial
Collaborator Contribution Carrying out clinical and entomological investigations in clinics and homes
Impact Multi-disciplinary: Entomology, public health
Start Year 2016
 
Description Dengue Index 
Organisation Norwegian University of Life Sciences (NMBU)
Country Norway 
Sector Academic/University 
PI Contribution Design and analysis of case-control study and cluster-randomized trial
Collaborator Contribution Carrying out clinical and entomological investigations in clinics and homes
Impact Multi-disciplinary: Entomology, public health
Start Year 2016
 
Description Design and analysis of clinical trials for the treatment of Visceral Leishmaniasis 
Organisation Drugs for Neglected Diseases initiative (DNDi)
Country Switzerland 
Sector Charity/Non Profit 
PI Contribution Contributed to design and analysis of clinical trials, continued capacity building in data management, study design and analysis methods, preparation of successful grant applications, project management
Collaborator Contribution Sponsorship of clinical trials, intellectual input, project management, leadership
Impact Trials ongoing. Demonstration of ability to conduct rigorous research in the context of a public health emergency and engage affected communities in a volatile stigmatised environment. Multi-disciplinary - Statistics, clinical, public health.
Start Year 2013
 
Description Design and analysis of clinical trials for the treatment of Visceral Leishmaniasis 
Organisation Institute of Tropical Medicine Antwerp
Country Belgium 
Sector Academic/University 
PI Contribution Contributed to design and analysis of clinical trials, continued capacity building in data management, study design and analysis methods, preparation of successful grant applications, project management
Collaborator Contribution Sponsorship of clinical trials, intellectual input, project management, leadership
Impact Trials ongoing. Demonstration of ability to conduct rigorous research in the context of a public health emergency and engage affected communities in a volatile stigmatised environment. Multi-disciplinary - Statistics, clinical, public health.
Start Year 2013
 
Description Design and analysis of clinical trials for the treatment of Visceral Leishmaniasis 
Organisation Leishmaniasis East Africa Platform (LEAP)
Country Sudan 
Sector Public 
PI Contribution Contributed to design and analysis of clinical trials, continued capacity building in data management, study design and analysis methods, preparation of successful grant applications, project management
Collaborator Contribution Sponsorship of clinical trials, intellectual input, project management, leadership
Impact Trials ongoing. Demonstration of ability to conduct rigorous research in the context of a public health emergency and engage affected communities in a volatile stigmatised environment. Multi-disciplinary - Statistics, clinical, public health.
Start Year 2013
 
Description Drought, Poverty and HIV Drug Resistance: threat to resilience in a vulnerable rural settings 
Organisation Africa Health Research Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution study design; statistical advice, data linkage; analysis
Collaborator Contribution study design; coordination; field work; spatial epidemiology; economic modelling; climate science
Impact None yet. Multidisciplinary: epidemiology, public health, climate science, biostatistics, qualitative research
Start Year 2017
 
Description Drought, Poverty and HIV Drug Resistance: threat to resilience in a vulnerable rural settings 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution study design; statistical advice, data linkage; analysis
Collaborator Contribution study design; coordination; field work; spatial epidemiology; economic modelling; climate science
Impact None yet. Multidisciplinary: epidemiology, public health, climate science, biostatistics, qualitative research
Start Year 2017
 
Description Drought, Poverty and HIV Drug Resistance: threat to resilience in a vulnerable rural settings 
Organisation University of Sussex
Country United Kingdom 
Sector Academic/University 
PI Contribution study design; statistical advice, data linkage; analysis
Collaborator Contribution study design; coordination; field work; spatial epidemiology; economic modelling; climate science
Impact None yet. Multidisciplinary: epidemiology, public health, climate science, biostatistics, qualitative research
Start Year 2017
 
Description EIP trial 
Organisation Medical Research Council (MRC)
Department MRC/UVRI and LSHTM Research Unit Uganda
Country Uganda 
Sector Academic/University 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary - Epidemiology, public health
Start Year 2017
 
Description Eave Tubes 
Organisation Cote D'Ivoire's National Institute of Public Health
Country Cote d'Ivoire 
Sector Public 
PI Contribution Project statistician/epidemiologist- co-design of study and analysis; coordination with sample collection and fieldwork
Collaborator Contribution co-design; development of novel vector control product; field activities; entomological activities; lab analysis of samples
Impact Multi-disciplinary: epidemiology, public health, social science, entomology
Start Year 2016
 
Description Eave Tubes 
Organisation In2Care BV
Country Netherlands 
Sector Private 
PI Contribution Project statistician/epidemiologist- co-design of study and analysis; coordination with sample collection and fieldwork
Collaborator Contribution co-design; development of novel vector control product; field activities; entomological activities; lab analysis of samples
Impact Multi-disciplinary: epidemiology, public health, social science, entomology
Start Year 2016
 
Description Eave Tubes 
Organisation Penn State University
Country United States 
Sector Academic/University 
PI Contribution Project statistician/epidemiologist- co-design of study and analysis; coordination with sample collection and fieldwork
Collaborator Contribution co-design; development of novel vector control product; field activities; entomological activities; lab analysis of samples
Impact Multi-disciplinary: epidemiology, public health, social science, entomology
Start Year 2016
 
Description Eliminate Dengue Program 
Organisation Monash University
Department Eliminate Dengue Program
Country Australia 
Sector Academic/University 
PI Contribution Design of cluster randomised trial to evaluate effectiveness of large scale Wolbachia deployments on dengue transmission
Collaborator Contribution Facilitation and hosting of three workshops to design and plan trials in Indonesia and Vietnam
Impact Study protocol and draft manuscript on trial design. Multi-disciplinary - Epidemiology, Entomology, Infectious Disease Control, Statistics, Modelling.
Start Year 2015
 
Description Elimination Eight Partnerships 
Organisation Elimination Eight
Country Namibia 
Sector Private 
PI Contribution Technical advice and leadership for malaria elimination in 8 SADC countries
Collaborator Contribution Co-ordination of regional malaria elimnation strategies
Impact Multi-disciplinary: Epidemiology, Public Health
Start Year 2016
 
Description Epidemiology of alcohol use and alcohol use disorders among young people in northern Tanzania 
Organisation National Institute for Medical Research, Tanzania
Department NIMR Dar Es Salaam
Country Tanzania, United Republic of 
Sector Public 
PI Contribution PhD supervision (study design and supervision of analysis)
Collaborator Contribution Study design, co-ordination and analysis
Impact 4 papers published - included in publication section on researchfish submission. Multi-disciplinary: epidemiology, public health
Start Year 2011
 
Description Epidemiology of microcephaly and Zika in Pernambuco, Brasil 
Organisation Oswaldo Cruz Foundation (Fiocruz)
Country Brazil 
Sector Public 
PI Contribution Space/time analysis of data on incidence of microcephaly; estimation of incidence of Zika,
Collaborator Contribution Multiple population and hospital-based studies on microcephaly and Zika.
Impact None as yet.
Start Year 2016
 
Description Evaluation of an mHealth app for Ebola contact tracing 
Organisation Innovations for Poverty Action (IPA)
Country United States 
Sector Charity/Non Profit 
PI Contribution Design & analysis of a smartphone app to improve contact tracing and monitoring during the 2015 Ebola outbreak in Sierra Leone
Collaborator Contribution Development of the app
Impact Final analysis is ongoing. Multi disciplinary - Epidemiology, social science, technology
Start Year 2015
 
Description Evaluation of attractant targeted sugar baits for malaria prevention 
Organisation University of Bamako
Country Mali 
Sector Academic/University 
PI Contribution study design, protocol development, trial support, statistical analysis
Collaborator Contribution Entomology, sugar bait technology, fieldwork experience
Impact Multi-disciplinary: epidemiology, entomology, statistics, social science
Start Year 2018
 
Description Evaluation of convalescent Plasma for Ebola Virus Disease in Sierra Leone 
Organisation Institute of Tropical Medicine Antwerp
Country Belgium 
Sector Academic/University 
PI Contribution Contributing to design and analysis of clinical trials, preparation of successful grant applications, project management
Collaborator Contribution Sponsorship of clinical trials, intellectual input, project management, leadership
Impact Publication of trial findings in New England Journal of Medicine. Multi-disciplinary - Statistics, clinical, public health.
Start Year 2014
 
Description Evaluation of convalescent Plasma for Ebola Virus Disease in Sierra Leone 
Organisation University of Liverpool
Country United Kingdom 
Sector Academic/University 
PI Contribution Contributing to design and analysis of clinical trials, preparation of successful grant applications, project management
Collaborator Contribution Sponsorship of clinical trials, intellectual input, project management, leadership
Impact Publication of trial findings in New England Journal of Medicine. Multi-disciplinary - Statistics, clinical, public health.
Start Year 2014
 
Description Friendship Bench 
Organisation University of Zimbabwe
Country Zimbabwe 
Sector Academic/University 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health 3 papers published, details in publications section of researchfish submission Outcome - Scale-up of the Friendship Bench in Zimbabwe
Start Year 2013
 
Description GIS training 
Organisation Medical Research Council (MRC)
Department MRC Unit, The Gambia
Country Gambia 
Sector Public 
PI Contribution Developed material and gave training course at each institution
Collaborator Contribution Fieldwork during training
Impact Multi-disciplinary: GIS, epidemiology, statistics
Start Year 2018
 
Description GIS training 
Organisation Medical Research Council (MRC)
Department MRC/UVRI and LSHTM Research Unit Uganda
Country Uganda 
Sector Academic/University 
PI Contribution Developed material and gave training course at each institution
Collaborator Contribution Fieldwork during training
Impact Multi-disciplinary: GIS, epidemiology, statistics
Start Year 2018
 
Description GMZ2 Consortium 
Organisation Center of Medical Research Lambaréné
Country Gabon 
Sector Academic/University 
PI Contribution Design and analysis of the GMZ2 malaria vaccine trial
Collaborator Contribution Co-ordination of the field trial
Impact Final efficacy analysis is ongoing. This is a multi centre phase 2b vaccine trial so involves clinical, epidemiological, statistical and laboratory (immunology) expertise.
Start Year 2008
 
Description GMZ2 Consortium 
Organisation Makerere University College of Health Sciences
Country Uganda 
Sector Academic/University 
PI Contribution Design and analysis of the GMZ2 malaria vaccine trial
Collaborator Contribution Co-ordination of the field trial
Impact Final efficacy analysis is ongoing. This is a multi centre phase 2b vaccine trial so involves clinical, epidemiological, statistical and laboratory (immunology) expertise.
Start Year 2008
 
Description GMZ2 Consortium 
Organisation Medical Research Council (MRC)
Department MRC Unit, The Gambia
Country Gambia 
Sector Public 
PI Contribution Design and analysis of the GMZ2 malaria vaccine trial
Collaborator Contribution Co-ordination of the field trial
Impact Final efficacy analysis is ongoing. This is a multi centre phase 2b vaccine trial so involves clinical, epidemiological, statistical and laboratory (immunology) expertise.
Start Year 2008
 
Description GMZ2 Consortium 
Organisation Navrongo Health Research Centre (NHRC)
Country Ghana 
Sector Academic/University 
PI Contribution Design and analysis of the GMZ2 malaria vaccine trial
Collaborator Contribution Co-ordination of the field trial
Impact Final efficacy analysis is ongoing. This is a multi centre phase 2b vaccine trial so involves clinical, epidemiological, statistical and laboratory (immunology) expertise.
Start Year 2008
 
Description GMZ2 Consortium 
Organisation The Statens Serum Institute (SSI)
Country Denmark 
Sector Public 
PI Contribution Design and analysis of the GMZ2 malaria vaccine trial
Collaborator Contribution Co-ordination of the field trial
Impact Final efficacy analysis is ongoing. This is a multi centre phase 2b vaccine trial so involves clinical, epidemiological, statistical and laboratory (immunology) expertise.
Start Year 2008
 
Description Global mental health trials 
Organisation Sangath
Country India 
Sector Charity/Non Profit 
PI Contribution Statistical and epidemiological collaboration
Collaborator Contribution Leadership and all aspects of the trials
Impact Evidence to support the use of lay health workers in delivering psychosocial interventions in primary care clinics. Multi disciplinary - Epidemiology, statistics, clinical, public health
 
Description Gnatwork 
Organisation The Pirbright Institute
Country United Kingdom 
Sector Academic/University 
PI Contribution Setting up grant schemes, reviewing the resultant proposals, and training.
Collaborator Contribution As previous, plus administering the core scheme and the grants awarded.
Impact Multi-disciplinary: epidemiology, entomology, statistics, molecular biology
Start Year 2017
 
Description Good Health for Women Project 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Analysis of a long-term cohort of women at high risk of HIV
Collaborator Contribution Study co-ordination
Impact Multi-disciplinary: epidemiology, social science
Start Year 2016
 
Description HAYA 
Organisation Africa Health Research Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Suzanna Francis was Principal investigator leading the iGugu project
Collaborator Contribution Study was co-run with partners
Impact 1 paper; 4 conference presentations. Disciplines involved - Epidemiology; Social Science; Laboratory Science
Start Year 2015
 
Description HC-HIV IPD 
Organisation Family Health International
Country United States 
Sector Charity/Non Profit 
PI Contribution Protocol development and review of analysis and paper
Collaborator Contribution FHI was leading the project and carried out the analysis
Impact 1 paper. Impact: Impacted WHO policy on contraceptive use among women at high risk for HIV
Start Year 2012
 
Description HCBV 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Suzanna Francis is principal investigator
Collaborator Contribution 16SrRNA sequencing; metabolomics; Luminex testing; data collection
Impact No outputs yet. Disciplines include Epidemiology; Social Science; Laboratory Science
Start Year 2017
 
Description HCBV 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Suzanna Francis is principal investigator
Collaborator Contribution 16SrRNA sequencing; metabolomics; Luminex testing; data collection
Impact No outputs yet. Disciplines include Epidemiology; Social Science; Laboratory Science
Start Year 2017
 
Description HCBV 
Organisation University of Liverpool
Country United Kingdom 
Sector Academic/University 
PI Contribution Suzanna Francis is principal investigator
Collaborator Contribution 16SrRNA sequencing; metabolomics; Luminex testing; data collection
Impact No outputs yet. Disciplines include Epidemiology; Social Science; Laboratory Science
Start Year 2017
 
Description HDTstudy 
Organisation Aurum Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Study design and supervising analysis
Collaborator Contribution Study design, co-ordination, trial recruitment
Impact Multi-disciplinary: statistics, trial design, immunology
Start Year 2016
 
Description HIV Drug Resistance Elimination And Management Network 
Organisation Africa Health Research Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution study design; statistical advice, data linkage; analysis
Collaborator Contribution study design; coordination; field activities; organisation of workships;
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description HIV Drug Resistance Elimination And Management Network 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution study design; statistical advice, data linkage; analysis
Collaborator Contribution study design; coordination; field activities; organisation of workships;
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description HIV Drug Resistance Elimination And Management Network 
Organisation University of Sussex
Country United Kingdom 
Sector Academic/University 
PI Contribution study design; statistical advice, data linkage; analysis
Collaborator Contribution study design; coordination; field activities; organisation of workships;
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description HIV Prevention Trials 
Organisation WellcomeTrust Africa Centre
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Statistical collaboration at Africa Centre
Collaborator Contribution Leadership of Africa Centre
Impact Renewal of Africa Centre grant from Wellcome Trust. Multi-disciplinary - Epidemiology, statistics, economics, social science, clinical medicine, molecular biology
Start Year 2014
 
Description HIV Self-Testing in AfRica (STAR) 
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2015
 
Description HIV Self-Testing in AfRica (STAR) 
Organisation Liverpool School of Tropical Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2015
 
Description HIV Self-Testing in AfRica (STAR) 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2015
 
Description HIV Self-Testing in AfRica (STAR) 
Organisation Wellcome Trust
Department Malawi-Liverpool Wellcome Trust Clinical Research Programme
Country Malawi 
Sector Academic/University 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2015
 
Description HIV Self-Testing in AfRica (STAR) 
Organisation World Health Organization (WHO)
Department UNITAID
Country Switzerland 
Sector Public 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2015
 
Description HIV epidemiology in the Middle East and North Africa 
Organisation Weill Cornell Medical College in Qatar
Country Qatar 
Sector Academic/University 
PI Contribution PhD supervision
Collaborator Contribution Analysis and modelling
Impact 4 papers published, details in publications section of submission Multi-disciplinary: epidemiology, modelling
Start Year 2012
 
Description HIV self testing: Network distribution for linkage to PrEP and prevention in South Africa (AHRI) 
Organisation Africa Health Research Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution study design, sample size, statistical analysis
Collaborator Contribution study design, field activities
Impact Multi-disciplinary: epidemiology, statistics, social science
Start Year 2017
 
Description HIV self testing: Network distribution for linkage to PrEP and prevention in South Africa (AHRI) 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution study design, sample size, statistical analysis
Collaborator Contribution study design, field activities
Impact Multi-disciplinary: epidemiology, statistics, social science
Start Year 2017
 
Description HIV/VL India 
Organisation Médecins Sans Frontières (MSF)
Country France 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Leading clinical trial of drugs against visceral leishmaniasis in HIV co-infected patients
Impact Multi-disciplinary: epidemiology, public health
Start Year 2016
 
Description HPV Vaccine Trial - DoRIS 
Organisation University of York
Country United Kingdom 
Sector Academic/University 
PI Contribution Member of the team funded by this award is a PI on the grant.
Collaborator Contribution Co-investigator on grant; immunology assays for vaccine trial
Impact None yet
Start Year 2016
 
Description HPV vaccine trial - DoRIS 
Organisation Catalan Institute of Oncology (ICO)
Department Cancer Epidemiology Research Programme (PREC)
Country Spain 
Sector Hospitals 
PI Contribution Member of the team is PI on this grant.
Collaborator Contribution co-investigator on grant; HPV assays for vaccine trial
Impact None yet
Start Year 2016
 
Description HPV vaccine trial - DoRIS 
Organisation Karolinska Institute
Country Sweden 
Sector Academic/University 
PI Contribution Member of research team is PI on this grant.
Collaborator Contribution co-investigator on grant; immunology assays for vaccine trial
Impact None yet
Start Year 2016
 
Description HPV vaccine trial - DoRIS 
Organisation National Institutes of Health (NIH)
Department National Cancer Institute (NCI)
Country United States 
Sector Public 
PI Contribution Member of team is PI on this grant
Collaborator Contribution co-investigator on grant; immunology assays for vaccine trial
Impact None yet
Start Year 2016
 
Description HPV vaccine trial - DoRIS 
Organisation National Institutes of Health (NIH)
Country United States 
Sector Public 
PI Contribution sharing of HPV vaccine immunogenicity data
Collaborator Contribution sharing of HPV vaccine efficacy data for immunobridging
Impact None yet
Start Year 2016
 
Description HomeACF 
Organisation University of the Witwatersrand
Country South Africa 
Sector Academic/University 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: public health, health economics, statistics
Start Year 2016
 
Description IRD TB Programme Evaluation 
Organisation IRD Global
Country Pakistan 
Sector Charity/Non Profit 
PI Contribution Co-design of evaluation of TB control programme through prevalence surveys and will do the analysis
Collaborator Contribution Co-design and running of evaluation
Impact Multi-disciplinary: Epidemiology, public health, statistics
Start Year 2016
 
Description IVM Malaysia 
Organisation Bayer
Department Bayer CropScience Ltd
Country United Kingdom 
Sector Private 
PI Contribution Study design and analysis
Collaborator Contribution As previous, plus field and lab work.
Impact Multi-disciplinary: epidemiology, entomology, statistics, public health, social science
Start Year 2017
 
Description Ilorin-Gambia-LSHTM group on sickle cell disease 
Organisation Medical Research Council (MRC)
Department MRC Unit, The Gambia
Country Gambia 
Sector Public 
PI Contribution Design and coordination of the randomized trial
Collaborator Contribution Conducted the clinic-based trial
Impact Evidence to support policy change for the management of sickle cell patients in malaria endemic areas. This collaboration is multi-disciplinary involving clinical medicine, epidemioogy, statistics, molecular biology.
Start Year 2010
 
Description Ilorin-Gambia-LSHTM group on sickle cell disease 
Organisation University of Ilorin Teaching Hospital, Nigeria
Country Nigeria 
Sector Academic/University 
PI Contribution Design and coordination of the randomized trial
Collaborator Contribution Conducted the clinic-based trial
Impact Evidence to support policy change for the management of sickle cell patients in malaria endemic areas. This collaboration is multi-disciplinary involving clinical medicine, epidemioogy, statistics, molecular biology.
Start Year 2010
 
Description Improving the health systems response to chronic diseases in Africa 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Statistical support - analysis, reporting of results. PI and Tanzania PI based at MITU; study co-run by MITU
Collaborator Contribution Study co-run by MRC Uganda
Impact Number of manuscripts phase 1 (surveys): published 8. Phase 2: 2 papers in preparation. 1 book chapter published. Impacted on NCD control practice in Uganda and Tanzania. E.g. Tz introduced position of district NCD coordinators, District Mos allocated funds to purchase of NCD drugs. (These impacts are tangible but direct link to project difficult to prove).
Start Year 2011
 
Description Improving the health systems response to chronic diseases in Africa 
Organisation Ministry of Health and Social Welfare
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Statistical support - analysis, reporting of results. PI and Tanzania PI based at MITU; study co-run by MITU
Collaborator Contribution Study co-run by MRC Uganda
Impact Number of manuscripts phase 1 (surveys): published 8. Phase 2: 2 papers in preparation. 1 book chapter published. Impacted on NCD control practice in Uganda and Tanzania. E.g. Tz introduced position of district NCD coordinators, District Mos allocated funds to purchase of NCD drugs. (These impacts are tangible but direct link to project difficult to prove).
Start Year 2011
 
Description Improving the health systems response to chronic diseases in Africa 
Organisation National Institute for Medical Research, Tanzania
Department Mwanza Intervention Trials Unit (MITU)
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Statistical support - analysis, reporting of results. PI and Tanzania PI based at MITU; study co-run by MITU
Collaborator Contribution Study co-run by MRC Uganda
Impact Number of manuscripts phase 1 (surveys): published 8. Phase 2: 2 papers in preparation. 1 book chapter published. Impacted on NCD control practice in Uganda and Tanzania. E.g. Tz introduced position of district NCD coordinators, District Mos allocated funds to purchase of NCD drugs. (These impacts are tangible but direct link to project difficult to prove).
Start Year 2011
 
Description Infection prevention and control for drug-resistant tuberculosis in South Africa (AHRI) 
Organisation Africa Health Research Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution sample size, study design, statistical analysis, sampling
Collaborator Contribution study design, analysis, field activities
Impact Multi-disciplinary: epidemiology, statistics, modelling, social science
Start Year 2017
 
Description Leaving no-one behind 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Co-investigator
Collaborator Contribution Study co-ordination and analysis
Impact Discipline: social science
Start Year 2016
 
Description Lung disease in HIV infected children 
Organisation Biomedical Research and Training Institute (BRTI)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Statistical and epidemiological collaboration
Collaborator Contribution Leadership and all aspects of the trial
Impact Trial initiating in 2016.
Start Year 2014
 
Description Lung disease in HIV infected children 
Organisation University of Liverpool
Country United Kingdom 
Sector Academic/University 
PI Contribution Statistical and epidemiological collaboration
Collaborator Contribution Leadership and all aspects of the trial
Impact Trial initiating in 2016.
Start Year 2014
 
Description Lung disease in HIV infected children 
Organisation University of Tromso
Country Norway 
Sector Academic/University 
PI Contribution Statistical and epidemiological collaboration
Collaborator Contribution Leadership and all aspects of the trial
Impact Trial initiating in 2016.
Start Year 2014
 
Description MCUTS 
Organisation Grassroot Soccer
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact 2 papers published - detail in publications section of researchfish submission Multi-disciplinary: epidemiology, public health
Start Year 2013
 
Description MDR-TB infection control 
Organisation Queen Margaret University
Country United Kingdom 
Sector Academic/University 
PI Contribution co-design of study and analysis
Collaborator Contribution co-design, coordination, ethnographic work, policy review, laboratory work, health economics
Impact Multi-disciplinary: Epidemiology, public health, health economics, modelling, anthropology, statistics
Start Year 2017
 
Description MDR-TB infection control 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution co-design of study and analysis
Collaborator Contribution co-design, coordination, ethnographic work, policy review, laboratory work, health economics
Impact Multi-disciplinary: Epidemiology, public health, health economics, modelling, anthropology, statistics
Start Year 2017
 
Description MDR-TB infection control 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution co-design of study and analysis
Collaborator Contribution co-design, coordination, ethnographic work, policy review, laboratory work, health economics
Impact Multi-disciplinary: Epidemiology, public health, health economics, modelling, anthropology, statistics
Start Year 2017
 
Description MDR-TB infection control 
Organisation University of KwaZulu-Natal
Country South Africa 
Sector Academic/University 
PI Contribution co-design of study and analysis
Collaborator Contribution co-design, coordination, ethnographic work, policy review, laboratory work, health economics
Impact Multi-disciplinary: Epidemiology, public health, health economics, modelling, anthropology, statistics
Start Year 2017
 
Description MENISCUS 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Leadership, design and analysis
Collaborator Contribution Study co-ordination
Impact Outcome: Funding of JGHT trials development grant Multi-disciplinary: epidemiology, social science
Start Year 2015
 
Description MENISCUS2 
Organisation MRC/UVRI Uganda Research Unit on AIDS
Country Uganda 
Sector Public 
PI Contribution Leadership, design and analysis
Collaborator Contribution Study co-ordination
Impact Multi-disciplinary: epidemiology, social science
Start Year 2017
 
Description MTV Shuga Evaluation 
Organisation Africa Health Research Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution co-investigator; study design and analysis
Collaborator Contribution Design and running of evaluation
Impact No outputs yet. Disciplines include epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description MTV Shuga Evaluation 
Organisation Epicentre
Country United States 
Sector Private 
PI Contribution co-investigator; study design and analysis
Collaborator Contribution Design and running of evaluation
Impact No outputs yet. Disciplines include epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description MTV Shuga Evaluation 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution co-investigator; study design and analysis
Collaborator Contribution Design and running of evaluation
Impact No outputs yet. Disciplines include epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description Management of child malnutrition in India 
Organisation Médecins Sans Frontières (MSF)
Country France 
Sector Charity/Non Profit 
PI Contribution study design & analysis
Collaborator Contribution study design & analysis, field visits
Impact None yet. Multi-disciplinary: clinical trials, epidemiology, public health, statistics
Start Year 2017
 
Description Monitoring and Evaluation of implementation of interventions for VL in Africa and Asia 
Organisation Drugs for Neglected Diseases initiative (DNDi)
Country Switzerland 
Sector Charity/Non Profit 
PI Contribution Contributing to design and analysis of surveys
Collaborator Contribution Project management, intellectual input
Impact Multi disciplinary - Epidemiology, public health, statistics
Start Year 2014
 
Description Monitoring and Evaluation of implementation of interventions for VL in Africa and Asia 
Organisation Mott Macdonald UK Ltd
Country United Kingdom 
Sector Private 
PI Contribution Contributing to design and analysis of surveys
Collaborator Contribution Project management, intellectual input
Impact Multi disciplinary - Epidemiology, public health, statistics
Start Year 2014
 
Description Monitoring and Evaluation of implementation of interventions for VL in Africa and Asia 
Organisation Médecins Sans Frontières (MSF)
Country France 
Sector Charity/Non Profit 
PI Contribution Contributing to design and analysis of surveys
Collaborator Contribution Project management, intellectual input
Impact Multi disciplinary - Epidemiology, public health, statistics
Start Year 2014
 
Description Namibia Malaria Elimination Partnership (NAMEP) 
Organisation Clinton Health Access Initiative
Country United States 
Sector Charity/Non Profit 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance; support to namtional Malaria Control programme
Impact "Trial Protocol; Smith, J. L., Auala, J., Haindongo, E., Uusiku, P., Gosling, R., Kleinschmidt, I., Mumbengegwi, D., Sturrock, H. J. W. (2017). Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malaria Journal, 16, 70. http://doi.org/10.1186/s12936-017-1719-x" Multi-disciplinary: Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Namibia Malaria Elimination Partnership (NAMEP) 
Organisation National Vector-borne Diseases Control Programme (NVDCP)
Country Namibia 
Sector Public 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance; support to namtional Malaria Control programme
Impact "Trial Protocol; Smith, J. L., Auala, J., Haindongo, E., Uusiku, P., Gosling, R., Kleinschmidt, I., Mumbengegwi, D., Sturrock, H. J. W. (2017). Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malaria Journal, 16, 70. http://doi.org/10.1186/s12936-017-1719-x" Multi-disciplinary: Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Namibia Malaria Elimination Partnership (NAMEP) 
Organisation University of California, San Francisco
Country United States 
Sector Academic/University 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance; support to namtional Malaria Control programme
Impact "Trial Protocol; Smith, J. L., Auala, J., Haindongo, E., Uusiku, P., Gosling, R., Kleinschmidt, I., Mumbengegwi, D., Sturrock, H. J. W. (2017). Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malaria Journal, 16, 70. http://doi.org/10.1186/s12936-017-1719-x" Multi-disciplinary: Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Namibia Malaria Elimination Partnership (NAMEP) 
Organisation University of Namibia
Country Namibia 
Sector Academic/University 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance; support to namtional Malaria Control programme
Impact "Trial Protocol; Smith, J. L., Auala, J., Haindongo, E., Uusiku, P., Gosling, R., Kleinschmidt, I., Mumbengegwi, D., Sturrock, H. J. W. (2017). Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malaria Journal, 16, 70. http://doi.org/10.1186/s12936-017-1719-x" Multi-disciplinary: Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Namibia Malaria Elimination Partnership (NAMEP) 
Organisation University of the Witwatersrand
Country South Africa 
Sector Academic/University 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance; support to namtional Malaria Control programme
Impact "Trial Protocol; Smith, J. L., Auala, J., Haindongo, E., Uusiku, P., Gosling, R., Kleinschmidt, I., Mumbengegwi, D., Sturrock, H. J. W. (2017). Malaria risk in young male travellers but local transmission persists: a case-control study in low transmission Namibia. Malaria Journal, 16, 70. http://doi.org/10.1186/s12936-017-1719-x" Multi-disciplinary: Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description New nets project 
Organisation Entomological Research Centre of Cotonou (CREC)
Country Benin 
Sector Academic/University 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution field activities
Impact Multi-disciplinary: epidemiology, vector control, entomology
Start Year 2018
 
Description Newton Household Screening - Aurum (Asibamisane) 
Organisation Aurum Institute
Country South Africa 
Sector Charity/Non Profit 
PI Contribution Study design and analysis
Collaborator Contribution Study design and co-ordination
Impact Multi-disciplinary: public health, health economics, statistics, qualitative
Start Year 2016
 
Description OFLOTUB 
Organisation Ignace Deen Hospital
Country Guinea 
Sector Hospitals 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation Institute of Development Research (IRD)
Country France 
Sector Academic/University 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation Institute of Tropical Medicine Antwerp
Country Belgium 
Sector Academic/University 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation Medical Research Council of South Africa (MRC)
Country South Africa 
Sector Public 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation National Hospital of Pneumo-Phtisiology
Country Benin 
Sector Hospitals 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation Programme National de Lutte contre la Tuberculose
Country Senegal 
Sector Public 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation University Hospitals in Paris
Country France 
Sector Academic/University 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description OFLOTUB 
Organisation World Health Organization (WHO)
Department Tropical Disease Research (TDR)
Country Switzerland 
Sector Public 
PI Contribution Contributed to trial design, conduct of trial, statistical support, data analysis
Collaborator Contribution Significant intellectual input and exchange of ideas
Impact Results presented at the Union TB conference in Paris, 2013. Paper published on trial design (Trials, 2012) and main trial results (NEJM, 2014).
 
Description PANGEA 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution We will be contributing specimens (from PopART trial) to an international collaboration using sequencing and phylogenetic analysis to better understand the transmission dynamics of HIV.
Collaborator Contribution Co-ordination; organisation of sequencing pipeline; workshops; financial management.
Impact Multi-disciplinary: Epidemiology, public health
Start Year 2013
 
Description POPVAC trials 
Organisation Medical Research Council (MRC)
Department MRC/UVRI and LSHTM Research Unit Uganda
Country Uganda 
Sector Academic/University 
PI Contribution study design and set up, study anlaysis
Collaborator Contribution field activities, trial management, study design
Impact Multi-disciplinary: statistics, clinical trials, immunology, public health
Start Year 2018
 
Description PREMIUM 
Organisation Sangath
Country India 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact 3 papers published, detail in publications section of submission Multi-disciplinary: epidemiology, public health
Start Year 2010
 
Description PRIDE 
Organisation Harvard University
Country United States 
Sector Academic/University 
PI Contribution Statistical support
Collaborator Contribution Study design, implementation and evaluation
Impact one publication, main results paper submitted. Multidisciplinary: epidemiology, psychiatry
Start Year 2017
 
Description PROSPECT study 
Organisation University of Liverpool
Country United Kingdom 
Sector Academic/University 
PI Contribution statistical advice
Collaborator Contribution study design; coordination; field activities; analysis
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2017
 
Description PROSPECT study 
Organisation Wellcome Trust
Department Malawi-Liverpool Wellcome Trust Clinical Research Programme
Country Malawi 
Sector Academic/University 
PI Contribution statistical advice
Collaborator Contribution study design; coordination; field activities; analysis
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2017
 
Description Paediatric praziquantel 
Organisation Brown University
Country United States 
Sector Academic/University 
PI Contribution study design; statistical advice; analysis
Collaborator Contribution study design; coordination; field activities
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2017
 
Description Paediatric praziquantel 
Organisation Medical Research Council (MRC)
Department MRC/UVRI and LSHTM Research Unit Uganda
Country Uganda 
Sector Academic/University 
PI Contribution study design; statistical advice; analysis
Collaborator Contribution study design; coordination; field activities
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2017
 
Description Paediatric praziquantel 
Organisation Ministry of Health, Uganda
Country Uganda 
Sector Public 
PI Contribution study design; statistical advice; analysis
Collaborator Contribution study design; coordination; field activities
Impact None yet. Multidisciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2017
 
Description Pangea2 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution We will be contributing specimens (from PopART trial) to an international collaboration using sequencing and phylogenetic analysis to better understand the transmission dynamics of HIV.
Collaborator Contribution Co-ordination; organisation of sequencing pipeline; workshops; financial management.
Impact None yet. Multidisciplinary: Epidemiology, public health, molecular epidemiology,virology
Start Year 2018
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Bill and Melinda Gates Foundation
Country United States 
Sector Charity/Non Profit 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Centers for Disease Control and Prevention (CDC)
Country United States 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Georgia Institute of Technology
Country United States 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Ghana Health Service
Country Ghana 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Health Protection and Research Organisation (HPRO)
Country Afghanistan 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation HealthNet
Country Afghanistan 
Sector Charity/Non Profit 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Ifakara Health Institute
Country Tanzania, United Republic of 
Sector Charity/Non Profit 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Karolinska Institute
Department Department of Public Health Sciences
Country Sweden 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Kilimanjaro Christian Medical Centre (KCMS)
Country Tanzania, United Republic of 
Sector Hospitals 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Kintampo Health Research Centre
Country Ghana 
Sector Hospitals 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Liverpool School of Tropical Medicine
Country United Kingdom 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Makerere University
Country Uganda 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Merlin, Afghanistan
Country Afghanistan 
Sector Private 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Ministry of Health, Uganda
Country Uganda 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation National Institute for Medical Research, Tanzania
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation National Malaria Control Programme, Cambodia
Country Cambodia 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation National Malaria Control Programme, Tanzania
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation University of California, San Francisco
Country United States 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation University of Copenhagen
Country Denmark 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation University of Malawi
Country Malawi 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation University of Nigeria
Country Nigeria 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation University of Yaoundé
Country Cameroon 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: Consortium for research on delivery of artemisinin combination therapy (ACT) 
Organisation Zanzibar Malaria Control Program
Country Tanzania, United Republic of 
Sector Academic/University 
PI Contribution Statistical advice, study design
Collaborator Contribution Intellectual input and mutual exchange of ideas; financial contribution; access to data and facilities
Impact Progress in research on delivery of artemisinin combination therapy; uptake of rapid diagnostic tests (RDTs) and health facility training with associated effects on diagnostic practices and patient outcomes; secondary analysis of trial data and preparation of cross-cutting papers; modelling of long-acting ACT for malaria case-management
Start Year 2008
 
Description Partnership: TB preventive therapy and case finding with the consortium to respond effectively to the AIDS and TB epidemics (CREATE) 
Organisation Johns Hopkins University
Country United States 
Sector Academic/University 
PI Contribution TEG has contributed to the design of two clinical trials: Zamstar and Thibela TB. We have also developed the trial protocols and provided statistical support and led on data analysis.
Collaborator Contribution Collaborative involvement in statistical analysis of cluster randomised trials and data management of large field-based studies
Impact Both trials have been completed successfully. Zamstar results presented at Union World Conference on Lung Health (2011) and CROI (2012). Thibela results presented at CROI (2012) and the South African TB Conference (2012). Trial results have been published - Zamstar in Lancet (2013) and Thibela in NEJM (2014). Several publications are in progress and we intend to apply the learning from both trials to future trial design.
Start Year 2006
 
Description PopART modelling and phylogenetics 
Organisation University of Oxford
Country United Kingdom 
Sector Academic/University 
PI Contribution study design, coordination, publications
Collaborator Contribution mathematical modelling, phylogenetics/sequencing
Impact Poster at CROI conference Multi-disciplinary: modelling, sequencing, epidemiology Information sheet on their Best Practices Compendium of evidence-based interventions for HIV prevention
Start Year 2018
 
Description PrEP demonstration projectc 
Organisation University College London
Country United Kingdom 
Sector Academic/University 
PI Contribution co-design of study and analysis; coordination of project at the Africa Centre site
Collaborator Contribution co-design, coordination of project at 2 other sites (Cape Town & Soweto)
Impact Multi-disciplinary: epidemiology, public health, health economics, social science, statistics
Start Year 2016
 
Description PrEP demonstration projectc 
Organisation University of Cape Town
Department Desmond Tutu HIV Centre
Country South Africa 
Sector Academic/University 
PI Contribution co-design of study and analysis; coordination of project at the Africa Centre site
Collaborator Contribution co-design, coordination of project at 2 other sites (Cape Town & Soweto)
Impact Multi-disciplinary: epidemiology, public health, health economics, social science, statistics
Start Year 2016
 
Description PrEP demonstration projectc 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution co-design of study and analysis; coordination of project at the Africa Centre site
Collaborator Contribution co-design, coordination of project at 2 other sites (Cape Town & Soweto)
Impact Multi-disciplinary: epidemiology, public health, health economics, social science, statistics
Start Year 2016
 
Description PrEP demonstration projectc 
Organisation University of the Witwatersrand
Department Perinatal HIV Research Unit
Country South Africa 
Sector Academic/University 
PI Contribution co-design of study and analysis; coordination of project at the Africa Centre site
Collaborator Contribution co-design, coordination of project at 2 other sites (Cape Town & Soweto)
Impact Multi-disciplinary: epidemiology, public health, health economics, social science, statistics
Start Year 2016
 
Description Preparing for clinical trials of interventions to improve the reproductive health of adolescent girls in sub-Saharan Africa 
Organisation Institute of Tropical Medicine Antwerp
Country Belgium 
Sector Academic/University 
PI Contribution study design, statistical analysis, co-investigators
Collaborator Contribution priniciple investiagor; sample testing; significant intellectual input and exchange of ideas
Impact Results pending; analyses currently underway
Start Year 2012
 
Description Preparing for clinical trials of interventions to improve the reproductive health of adolescent girls in sub-Saharan Africa 
Organisation National Institute for Medical Research, Tanzania
Department Mwanza Intervention Trials Unit (MITU)
Country Tanzania, United Republic of 
Sector Public 
PI Contribution study design, statistical analysis, co-investigators
Collaborator Contribution priniciple investiagor; sample testing; significant intellectual input and exchange of ideas
Impact Results pending; analyses currently underway
Start Year 2012
 
Description Preparing for clinical trials of interventions to improve the reproductive health of adolescent girls in sub-Saharan Africa 
Organisation National Institute for Medical Research, Tanzania
Department NIMR Mbeya Research Centre
Country Tanzania, United Republic of 
Sector Academic/University 
PI Contribution study design, statistical analysis, co-investigators
Collaborator Contribution priniciple investiagor; sample testing; significant intellectual input and exchange of ideas
Impact Results pending; analyses currently underway
Start Year 2012
 
Description REEHAD study, The Role of Environmental Enteropathy on HIV-Associated Diabetes 
Organisation National Institute for Medical Research, Tanzania
Country Tanzania, United Republic of 
Sector Public 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution field activities
Impact Multi-disciplinary: Nutrition, epidemiology, gastroenterology
Start Year 2019
 
Description RIFASHORT trial 
Organisation St George's University of London
Country United Kingdom 
Sector Academic/University 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution trial design and coordination, field activities
Impact Multi-disciplinary: epidemiology, public health, statistics, clinical trials
Start Year 2016
 
Description RKSK evaluation 
Organisation Public Health Foundation of India
Country India 
Sector Public 
PI Contribution Co-design of evaluation of governmental adolescent health programme ("RKSK") and will do the analysis
Collaborator Contribution Co-design and running of evaluation
Impact Outcome: successful grant application to the MRC Multi-disciplinary: Epidemiology, public health, statistics
Start Year 2016
 
Description RTS,S-SMC trial 
Organisation National Center for Scientific and Technological Research (CNRST)
Department Institute of Research in Health Sciences
Country Burkina Faso 
Sector Public 
PI Contribution Study design, analysis
Collaborator Contribution Clinical, field, lab studies
Impact None yet, (main trial paper later in 2020) Multidisciplinary: epidemiology, statistics, clinical trials
Start Year 2017
 
Description RTS,S-SMC trial 
Organisation University of Bamako
Department Malaria Research and Training Centre (MRTC) Bamako
Country Mali 
Sector Academic/University 
PI Contribution Study design, analysis
Collaborator Contribution Clinical, field, lab studies
Impact None yet, (main trial paper later in 2020) Multidisciplinary: epidemiology, statistics, clinical trials
Start Year 2017
 
Description RifT Study 
Organisation Makerere University
Department Infectious Diseases Institute
Country Uganda 
Sector Academic/University 
PI Contribution Sample size and statistical advice
Collaborator Contribution study design and setup, coordination, protocol writing, ethics applications
Impact No outputs yet. Disciplines include clinical trials, epidemiology, public health, statistics
Start Year 2017
 
Description RifT Study 
Organisation Radboud University Nijmegen
Country Netherlands 
Sector Academic/University 
PI Contribution Sample size and statistical advice
Collaborator Contribution study design and setup, coordination, protocol writing, ethics applications
Impact No outputs yet. Disciplines include clinical trials, epidemiology, public health, statistics
Start Year 2017
 
Description SEHER 
Organisation Sangath
Country India 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2013
 
Description STAMP 
Organisation Harvard University
Country United States 
Sector Academic/University 
PI Contribution Chief-Investigator, Study design and analysis
Collaborator Contribution Study design, co-ordination, economic modelling, trial recruitment
Impact PMID: 27007773; 27659507 ; 27638038; 26266773; 31781758; 30951533; 30683239; 30032978 Multi-disciplinary: public health, health economics, statistics
Start Year 2015
 
Description STAMP 
Organisation University of Cape Town
Country South Africa 
Sector Academic/University 
PI Contribution Chief-Investigator, Study design and analysis
Collaborator Contribution Study design, co-ordination, economic modelling, trial recruitment
Impact PMID: 27007773; 27659507 ; 27638038; 26266773; 31781758; 30951533; 30683239; 30032978 Multi-disciplinary: public health, health economics, statistics
Start Year 2015
 
Description STAMP 
Organisation Wellcome Trust
Department Malawi-Liverpool Wellcome Trust Clinical Research Programme
Country Malawi 
Sector Academic/University 
PI Contribution Chief-Investigator, Study design and analysis
Collaborator Contribution Study design, co-ordination, economic modelling, trial recruitment
Impact PMID: 27007773; 27659507 ; 27638038; 26266773; 31781758; 30951533; 30683239; 30032978 Multi-disciplinary: public health, health economics, statistics
Start Year 2015
 
Description STAR Malawi - secondary distribution of HIVST in ANC 
Organisation Wellcome Trust
Department Malawi-Liverpool Wellcome Trust Clinical Research Programme
Country Malawi 
Sector Academic/University 
PI Contribution Study design and statistical support
Collaborator Contribution Study co-ordination
Impact Multi-disciplinary: Epidemiology, economics, qualitative (most of these outputs are across more than one country) doi: 10.1136/bmjopen-2019-033435; 10.1002/jia2.25255; 10.1002/jia2.25238; 10.1097/QAD.0000000000001918; 10.1186/s12889-018-6120-3.
Start Year 2018
 
Description STAR Zambia - Cohort study of secondary distribution and case studies of distribution models 
Organisation University of Zambia
Department Zambart
Country Zambia 
Sector Academic/University 
PI Contribution Study design and statistical support
Collaborator Contribution Study coordination
Impact Multi-disciplinary: Epidemiology, economics, qualitative
Start Year 2018
 
Description STAR Zimbabwe 
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Study design and statistical support
Collaborator Contribution Study coordination
Impact Multi-disciplinary: Epidemiology, economics, qualitative
Start Year 2018
 
Description STIMA 
Organisation Centers for Disease Control and Prevention (CDC)
Country United States 
Sector Public 
PI Contribution Protocol development and review of analysis and paper
Collaborator Contribution FHI was leading the project and carried out the analysis
Impact 1 paper.
Start Year 2014
 
Description STIMA 
Organisation Family Health International
Country United States 
Sector Charity/Non Profit 
PI Contribution Protocol development and review of analysis and paper
Collaborator Contribution FHI was leading the project and carried out the analysis
Impact 1 paper.
Start Year 2014
 
Description STIMA 
Organisation World Health Organization (WHO)
Country Global 
Sector Public 
PI Contribution Protocol development and review of analysis and paper
Collaborator Contribution FHI was leading the project and carried out the analysis
Impact 1 paper.
Start Year 2014
 
Description Scrub typhus India 
Organisation Christian Medical College, Vellore
Country India 
Sector Academic/University 
PI Contribution Study design and analysis
Collaborator Contribution As previous, plus field and lab work.
Impact Multi-disciplinary: epidemiology, clinical science, entomology, statistics, diagnostic assays.
Start Year 2018
 
Description Secondment to Nagasaki University 
Organisation Nagasaki University
Country Japan 
Sector Academic/University 
PI Contribution Secondment to Nagasaki University (50%) to support research including TB & NCDs in the Philippines, epidemics, malaria. study design & analysis
Collaborator Contribution study design & analysis, field visits
Impact two papers submitted, two in preparation Multi-disciplinary: epidemiology, public health, statistics
Start Year 2018
 
Description Severe corneal infections 
Organisation Kilimanjaro Christian Medical Centre (KCMS)
Country Tanzania, United Republic of 
Sector Hospitals 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution Study coordination
Impact Multidisciplinary: epidemiology, public health, statistics
Start Year 2018
 
Description Severe corneal infections 
Organisation Mbarara National Referral Hospital
Country Uganda 
Sector Hospitals 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution Study coordination
Impact Multidisciplinary: epidemiology, public health, statistics
Start Year 2018
 
Description Severe corneal infections 
Organisation Sagarmatha Choudhary Eye Hospital
Country Nepal 
Sector Hospitals 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution Study coordination
Impact Multidisciplinary: epidemiology, public health, statistics
Start Year 2018
 
Description Spatial intelligence system for precision larviciding 
Organisation Aberystwyth University
Country United Kingdom 
Sector Academic/University 
PI Contribution sample size, study design, statistical analysis, data management
Collaborator Contribution trial design and coordination, field activities
Impact Multi-disciplinary: epidemiology, vector control, geography, spatial
Start Year 2018
 
Description Statistical support: Mwanza MITU/NIMR 
Organisation National Institute for Medical Research, Tanzania
Department Mwanza Intervention Trials Unit (MITU)
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Epidemiological and statistical input to field studies; design of new studies and preparation of funding applications; capacity building
Collaborator Contribution Collaborative involvement in and field sites for studies of the epidemiology and control of HIV and related infections
Impact HIV microbicide and vaccine feasibility studies, and studies of HPV vaccination and epidemiology successfully completed. Studies of chronic diseases and structural interventions to reduce gender violence ongoing
Start Year 2006
 
Description Stepped wedge trial analysis 
Organisation Monash University
Country Australia 
Sector Academic/University 
PI Contribution Project leaders, design of simulation study, conduct analysis, writing paper
Collaborator Contribution Design of simulation study, expertise in methods, contributing to paper writing
Impact Oral presentation at the International Conference on Stepped Wedge Trial Design, UK, and at the Meeting for Current Developments in Cluster Randomised Trials and Stepped Wedge Designs, UK. Multi-disciplinary: Statistics, Clinical Trials
Start Year 2018
 
Description Stepped wedge trial analysis 
Organisation University of Birmingham
Country United Kingdom 
Sector Academic/University 
PI Contribution Project leaders, design of simulation study, conduct analysis, writing paper
Collaborator Contribution Design of simulation study, expertise in methods, contributing to paper writing
Impact Oral presentation at the International Conference on Stepped Wedge Trial Design, UK, and at the Meeting for Current Developments in Cluster Randomised Trials and Stepped Wedge Designs, UK. Multi-disciplinary: Statistics, Clinical Trials
Start Year 2018
 
Description Stronger SAFE 
Organisation Fred Hollows Foundation
Country Australia 
Sector Charity/Non Profit 
PI Contribution Study design, statistical advice, analysis
Collaborator Contribution study design; coordination; field work; economic modelling;
Impact No outputs yet. Disciplines include epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description Stronger SAFE 
Organisation The Wellcome Trust Sanger Institute
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Study design, statistical advice, analysis
Collaborator Contribution study design; coordination; field work; economic modelling;
Impact No outputs yet. Disciplines include epidemiology, public health, statistics, qualitative research
Start Year 2017
 
Description TB & NCDs in the Philippines 
Organisation Nagasaki University
Country Japan 
Sector Academic/University 
PI Contribution study design & analysis
Collaborator Contribution study design & analysis, field visits
Impact none yet. Multidisciplinary: epidemiology, public health, statistics
Start Year 2016
 
Description TB China: CRT of medication monitor in TB case management 
Organisation Bill and Melinda Gates Foundation
Country United States 
Sector Charity/Non Profit 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Expertise in TB epidemiology, field studies
Impact Design of current cluster-randomized trial including economic costing of intervention; ongoing analysis of previous trial. Disciplines involved - Epidemiology, public health, health economics
Start Year 2010
 
Description TB China: CRT of medication monitor in TB case management 
Organisation Chinese Center for Disease Control and Prevention (China CDC)
Country China 
Sector Public 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Expertise in TB epidemiology, field studies
Impact Design of current cluster-randomized trial including economic costing of intervention; ongoing analysis of previous trial. Disciplines involved - Epidemiology, public health, health economics
Start Year 2010
 
Description TB China: CRT of medication monitor in TB case management 
Organisation Government of China
Department Ministry of Health of the People's Republic of China
Country China 
Sector Public 
PI Contribution Contributed to trial design, statistical support, data analysis
Collaborator Contribution Expertise in TB epidemiology, field studies
Impact Design of current cluster-randomized trial including economic costing of intervention; ongoing analysis of previous trial. Disciplines involved - Epidemiology, public health, health economics
Start Year 2010
 
Description TB adherence 
Organisation University of Edinburgh
Country United Kingdom 
Sector Academic/University 
PI Contribution Collaboration with Dr Helen Stagg on measuring adherence to TB treatment
Collaborator Contribution Collaboration with Prof Katherine Fielding on measuring adherence to TB treatment
Impact Multi-disciplinary: epidemiology, public health, statistics. Paper published- doi: 10.1513/AnnalsATS.201905-394OC
Start Year 2018
 
Description TB042 
Organisation Medical Research Council (MRC)
Department MRC/UVRI and LSHTM Research Unit Uganda
Country Uganda 
Sector Academic/University 
PI Contribution trial statistician
Collaborator Contribution trial design and coordination; field activities
Impact None yet. Multidisciplinary: public health, vaccines, clinical trials
Start Year 2018
 
Description TB042 
Organisation University of Oxford
Country United Kingdom 
Sector Academic/University 
PI Contribution trial statistician
Collaborator Contribution trial design and coordination; field activities
Impact None yet. Multidisciplinary: public health, vaccines, clinical trials
Start Year 2018
 
Description TREATS 
Organisation HST
PI Contribution Epidemiological and statistical input to study design and analysis. Liaison between TREATS and parent PopART trial.
Collaborator Contribution Expertise in TB epidemiology, diagnostics, field studies and modelling
Impact None yet. Multidisciplinary: Epidemiology, public health, diagnostics, modelling
Start Year 2017
 
Description TREATS 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Epidemiological and statistical input to study design and analysis. Liaison between TREATS and parent PopART trial.
Collaborator Contribution Expertise in TB epidemiology, diagnostics, field studies and modelling
Impact None yet. Multidisciplinary: Epidemiology, public health, diagnostics, modelling
Start Year 2017
 
Description TREATS 
Organisation International Union Against Tuberculosis and Lung Disease (The Union)
Country Global 
Sector Academic/University 
PI Contribution Epidemiological and statistical input to study design and analysis. Liaison between TREATS and parent PopART trial.
Collaborator Contribution Expertise in TB epidemiology, diagnostics, field studies and modelling
Impact None yet. Multidisciplinary: Epidemiology, public health, diagnostics, modelling
Start Year 2017
 
Description TREATS 
Organisation Royal Netherlands Chemical Society
Country Netherlands 
Sector Learned Society 
PI Contribution Epidemiological and statistical input to study design and analysis. Liaison between TREATS and parent PopART trial.
Collaborator Contribution Expertise in TB epidemiology, diagnostics, field studies and modelling
Impact None yet. Multidisciplinary: Epidemiology, public health, diagnostics, modelling
Start Year 2017
 
Description TREATS 
Organisation University of Sheffield
Country United Kingdom 
Sector Academic/University 
PI Contribution Epidemiological and statistical input to study design and analysis. Liaison between TREATS and parent PopART trial.
Collaborator Contribution Expertise in TB epidemiology, diagnostics, field studies and modelling
Impact None yet. Multidisciplinary: Epidemiology, public health, diagnostics, modelling
Start Year 2017
 
Description TREATS 
Organisation Zambia AIDS Related Tuberculosis
Country Zambia 
Sector Academic/University 
PI Contribution Epidemiological and statistical input to study design and analysis. Liaison between TREATS and parent PopART trial.
Collaborator Contribution Expertise in TB epidemiology, diagnostics, field studies and modelling
Impact None yet. Multidisciplinary: Epidemiology, public health, diagnostics, modelling
Start Year 2017
 
Description Targetted control to eliminate malaria in Senegal 
Organisation University Cheikh Anta Diop de Dakar
Country Senegal 
Sector Academic/University 
PI Contribution Design and coordination and analysis of the cluster randomized trial
Collaborator Contribution They led the coordination of field activities
Impact The trial result will be available Q4 2015. This collaboration is multi-disciplinary involving epidemiology, statistics, economics, social science, clinical medicine, molecular biology, entomology, public health, parasitology.
Start Year 2011
 
Description Trial to evaluate targeted parasite elimination (TPE) as a strategy to interrupt malaria transmission 
Organisation Clinton Health Access Initiative
Country United States 
Sector Charity/Non Profit 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance
Impact Trial protocol. Multi disciplinary - Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Trial to evaluate targeted parasite elimination (TPE) as a strategy to interrupt malaria transmission 
Organisation National Vector-borne Diseases Control Programme (NVDCP)
Country Namibia 
Sector Public 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance
Impact Trial protocol. Multi disciplinary - Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Trial to evaluate targeted parasite elimination (TPE) as a strategy to interrupt malaria transmission 
Organisation University of California, San Francisco
Country United States 
Sector Academic/University 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance
Impact Trial protocol. Multi disciplinary - Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Trial to evaluate targeted parasite elimination (TPE) as a strategy to interrupt malaria transmission 
Organisation University of Namibia
Country Namibia 
Sector Academic/University 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance
Impact Trial protocol. Multi disciplinary - Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description Trial to evaluate targeted parasite elimination (TPE) as a strategy to interrupt malaria transmission 
Organisation University of the Witwatersrand
Country South Africa 
Sector Academic/University 
PI Contribution Trial design; funding of vector control component through Wits University.
Collaborator Contribution Funding of trial; logistics; trial management and governance
Impact Trial protocol. Multi disciplinary - Epidemiology, Disease Control, Pharmacology, Entomology. Vector Control, Statistics. Modelling, Immunology
Start Year 2015
 
Description UT3C (Universal Testing and Treatment Trials Consortium) 
Organisation National Institute for Medical Research, Tanzania
Department Mwanza Intervention Trials Unit (MITU)
Country Tanzania, United Republic of 
Sector Public 
PI Contribution Coordination of Consortium. Chairing of Consortium calls. Partnering in joint analyses and publications between PopART and other UTT trials.
Collaborator Contribution Partnering in joint analyses and publications.
Impact Joint paper on UTT trial designs. Disciplines include epidemiology and public health.
Start Year 2015
 
Description VMB S.Francis 
Organisation Imperial College London
Country United Kingdom 
Sector Academic/University 
PI Contribution Principal investigator - leading the project
Collaborator Contribution 16SrRNA sequencing; metabolomics; Luminex testing
Impact 2 papers and more in progress.Multidisciplinary: Epidemiology and laboratory science
Start Year 2013
 
Description VMB S.Francis 
Organisation The Wellcome Trust Sanger Institute
Country United Kingdom 
Sector Charity/Non Profit 
PI Contribution Principal investigator - leading the project
Collaborator Contribution 16SrRNA sequencing; metabolomics; Luminex testing
Impact 2 papers and more in progress.Multidisciplinary: Epidemiology and laboratory science
Start Year 2013
 
Description Vanderbilt-collaboration 
Organisation Vanderbilt University
Country United States 
Sector Academic/University 
PI Contribution Study design
Collaborator Contribution Study design
Impact Discipline: Trial design
Start Year 2016
 
Description XPEL TB 
Organisation University of California, San Francisco
Country United States 
Sector Academic/University 
PI Contribution Study design and analysis
Collaborator Contribution Study design and co-ordination
Impact Multi-disciplinary: public health, health economics, statistics PMID: 31720425
Start Year 2016
 
Description Xenomonitoring of lymphatic filariasis in Recife, Brazil 
Organisation Oswaldo Cruz Foundation (Fiocruz)
Country Brazil 
Sector Public 
PI Contribution Leadership (Anita Ramesh) of the project which aims to establish a xenomonitoring system
Collaborator Contribution Cynthia Braga is co-PI. CPqAM personnel working on the xenomonitoring project. Lab facilities.
Impact None so far this year.
 
Description ZikAlliance 
Organisation Heidelberg University
Country Germany 
Sector Academic/University 
PI Contribution Epidemiology of ZIKV with a focus on natural history, virus detection over time and disability.
Collaborator Contribution University of Sao Paolo, Brazil will carry out the field activities. Heidelberg leads the large Consortium and co-ordinate a study in pregnant women and children
Impact Multi-disciplinary: Epidemiology, public health, statistics
Start Year 2016
 
Description ZikAlliance 
Organisation Sao Paulo State University
Country Brazil 
Sector Academic/University 
PI Contribution Epidemiology of ZIKV with a focus on natural history, virus detection over time and disability.
Collaborator Contribution University of Sao Paolo, Brazil will carry out the field activities. Heidelberg leads the large Consortium and co-ordinate a study in pregnant women and children
Impact Multi-disciplinary: Epidemiology, public health, statistics
Start Year 2016
 
Description ZikaPLAN 
Organisation Umea University
Country Sweden 
Sector Academic/University 
PI Contribution Coordination of focus group and related activities on use of wearable technologies for protection against mosquito vectors of Zika and other arboviruses.
Collaborator Contribution Universidad del Valle will carry out the field activities.
Impact Multi-disciplinary - Social sciences, entomology, public health.
Start Year 2016
 
Description Zimbabwe study for Enhancing Testing and Improving Treatment of HIV in Children 
Organisation Biomedical Research and Training Institute (BRTI)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Statistical and epidemiological collaboration
Collaborator Contribution Leadership and all aspects of the trial
Impact Trial will finish mid 2016
Start Year 2012
 
Description Zvandiri 
Organisation Centre for Sexual Health and HIV AIDS Research Zimbabwe (CeSHHAR Zimbabwe)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2014
 
Description Zvandiri 
Organisation Viiv Healthcare
Country United Kingdom 
Sector Private 
PI Contribution Trial design and analysis
Collaborator Contribution Trial design and co-ordination
Impact Multi-disciplinary: epidemiology, public health
Start Year 2014
 
Description evaluation of GPS data 
Organisation Biomedical Research and Training Institute (BRTI)
Country Zimbabwe 
Sector Charity/Non Profit 
PI Contribution Study design, GIS support
Collaborator Contribution Data collection
Impact Paper being written
Start Year 2018
 
Title PopART (HPTN 071) 
Description Universal testing and treatment for HIV 
Type Therapeutic Intervention - Drug
Current Stage Of Development Late clinical evaluation
Year Development Stage Completed 2018
Development Status Under active development/distribution
Clinical Trial? Yes
Impact Promotion of HIV self-testing in Zambia 
URL https://www.hptn.org/research/studies/hptn071
 
Title slopepower 
Description Sample size calculator for Stata, to be used for repeated measures trials where dataset exists to enable estimation of covariance matrix 
Type Of Technology Software 
Year Produced 2018 
Open Source License? Yes  
Impact None as yet 
URL https://ideas.repec.org/c/boc/bocode/s458484.html
 
Title swpermute 
Description command for Stata to conduct a permutation test for stepped wedge trials 
Type Of Technology Software 
Year Produced 2017 
Open Source License? Yes  
Impact None as yet 
URL https://ideas.repec.org/c/boc/bocode/s458426.html
 
Description AIDSimpact conference 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact oral abstract accepted for talk on ZENITH trial of lay worker support for adolescent HIV viral suppression
Year(s) Of Engagement Activity 2017
 
Description ASTMH - J.Bradley 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral presentation in scientific session at ASTMH: Predicting mosquito infection rates and infection intensity from Plasmodium falciparum gametocyte density and sex ratio
Year(s) Of Engagement Activity 2017
 
Description ASTMH: ACCESS-SMC 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral presentation in symposium at ASTMH
Year(s) Of Engagement Activity 2017
URL http://www.access-smc.org
 
Description ASTMH: The Elimination Eight 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral presentation in scientific session at ASTMH. A multi-country initiative to accelerate elimination by reducing cross-border importation of malaria:The Elimination Eight
Year(s) Of Engagement Activity 2017
 
Description Adolescents 360 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact International Conference on Family Planning
Year(s) Of Engagement Activity 2018
 
Description Analysis of CRTs 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Analysis of cluster randomised trials with a small number of clusters, Oral presentation at International Society for Clinical Biostatisticians conference, Melbourne
Year(s) Of Engagement Activity 2018
 
Description Article in Significance - RSS Magazine 
Form Of Engagement Activity A magazine, newsletter or online publication
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Article by Richard Hayes titled "Randomising towns to fight HIV" - describes features in the design and analysis of a key HIV prevention trial in Africa that uses cluster randomisation.
Year(s) Of Engagement Activity 2018
 
Description BBC Future 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Vicky Simms interviewed by journalist for a story on BBC Future website about Friendship Bench
Year(s) Of Engagement Activity 2018
URL http://www.bbc.com/future/story/20181015-how-one-bench-and-a-team-of-grandmothers-can-beat-depressio...
 
Description BHIVA 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Poster presentation about design of nested study about uptake of HPTM 071 (PopART) interventions
Year(s) Of Engagement Activity 2013
 
Description China CRT I 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral presentation at Harvard, USA
Year(s) Of Engagement Activity 2017
 
Description China CRT II 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral presentation at Johns Hopkins University, USA
Year(s) Of Engagement Activity 2017
 
Description Cost effectiveness of reactive targetted indoor residual spraying 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Professional Practitioners
Results and Impact 4th Southern Africa Malaria Research Conference
Year(s) Of Engagement Activity 2018
 
Description DENCO 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Invited talk on how to clinical classification of dengue

Positive feedback on insightfulness of presentation into clinical classification of dengue
Year(s) Of Engagement Activity 2014
URL http://www.redaedes.org/curso/presentacion.htm
 
Description Digital Health Conference 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Evidence of the importance / use of satellite and other imagery in public health
Year(s) Of Engagement Activity 2017
 
Description Expert Women - BBC 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Media (as a channel to the public)
Results and Impact Kalpana Sabapathy was selected to attend an Expert Women World Service day at the BBC, to engage in media training.
Year(s) Of Engagement Activity 2018
 
Description IAS 2012 (KS) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral presentation on a systematic review and meta-analysis on uptake of home-based testing in SSA
Year(s) Of Engagement Activity 2012
 
Description IAS 2016 (KS) 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Evaluating home-based testing in the HPTN 071 (PopART) trial
Year(s) Of Engagement Activity 2016
 
Description Impact of insecticide resistance on the effectiveness of LLINs - current knowledge and gaps 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Patients, carers and/or patient groups
Results and Impact WHO convened Evidence Review Group to define the conditions for deployment of long-lasting insecticidal nets treated with a pyrethroid and the synergist piperonyl butoxide. WHO Global Malaria Programme draft recommendation on the deployment of bi-treated nets to be used in areas where malaria vectors are pyrethroid resistant
Year(s) Of Engagement Activity 2015
URL http://www.who.int/malaria/publications/atoz/use-of-pbo-treated-llins/en/
 
Description Interest Workshop 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Professional Practitioners
Results and Impact Oral presentation on experiences from the first year of the PopART intervention
Year(s) Of Engagement Activity 2015
 
Description LaVIISWA 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Oral abstract accepted for presentation at EAACI

None that we are aware of at this stage
Year(s) Of Engagement Activity 2014
 
Description Launch of LSHTM's new STI Research Interest Group (STIRIG) 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Professional Practitioners
Results and Impact A symposium was held to launch LSHTM's new STI Research Interest Group (two of the Directors, Suzanna Francis and Sarah Harman are members of the Tropical Epidemiology Group) and was open to both LSHTM staff and members of the general public/other institutions. It comprised several talks by both internal and external speakers, and was attended by approximately 80 people in addition to being livestreamed for reasons of accessibility, and to reach a wider national and international audience. The symposium generated multiple questions and lots of discussion, which was continued during a networking event held afterwards. Following the symposium STIRIG increased its internal membership at LSHTM and received numerous requests for further information and newsletters from external sources.
Year(s) Of Engagement Activity 2018
URL https://www.lshtm.ac.uk/research/centres-projects-groups/stirig
 
Description Leishmanasias sequential re-analysis at ASTMH 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Re-Analysis of a Sequential Three-Arm Randomized Trial of Ambisome in Combination with Sodium Stibogluconate or Miltefosine, and Miltefosine Monotherapy, for African Visceral Leishmaniasis
Year(s) Of Engagement Activity 2016
 
Description MITU symposium 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact MITU symposium on adolescent health in Africa
Year(s) Of Engagement Activity 2018
URL https://mitu.or.tz/mitu-celebrates-10-years-of-success-by-organising-a-symposium-on-adolescent-healt...
 
Description Microcephaly ASTMH 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Spatiotemporal Analysis of Population Risk of Congenital Microcephaly in Pernambuco State, Brazil
Year(s) Of Engagement Activity 2017
 
Description Microcephaly ASTMH II 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Estimating the Risk of Microcephaly After Zika Infection in Pregnancy in Pernambuco, Brazil, via a Mathematical Model of Population Infection Dynamics
Year(s) Of Engagement Activity 2018
 
Description Microcephaly IBC 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Estimating the Risk of Microcephaly After Zika Infection in Pregnancy in Pernambuco, Brazil, via a Mathematical Model of Population Infection Dynamics
Year(s) Of Engagement Activity 2018
 
Description Missing maps 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact 3 external and 3 internal mapping events
Year(s) Of Engagement Activity 2018
URL http://www.missingmaps.org
 
Description Missing maps 
Form Of Engagement Activity Participation in an activity, workshop or similar
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact A series of evening sessions mapping areas for public health groups such as MSF, Red Cross and LSHTM. Four sessions, with between 60 - 100 people at each
Year(s) Of Engagement Activity 2017
URL http://www.missingmaps.org
 
Description NAC Annual Meeting 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact presentation at Zimbabwe National AIDS Conference
Year(s) Of Engagement Activity 2017
 
Description NutSoc Winter conference 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach National
Primary Audience Professional Practitioners
Results and Impact Poster Presentation at NutSoc winter conference
Year(s) Of Engagement Activity 2017
URL https://www.cambridge.org/core/journals/proceedings-of-the-nutrition-society
 
Description OFLOTUB Late Breaker 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Presentation generated lively discussion

Several tweets and news articles online
Year(s) Of Engagement Activity 2013
 
Description OFLOTUB Podcast 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Public/other audiences
Results and Impact Increased awareness of TB treatment trials

None that we are aware of at this stage
Year(s) Of Engagement Activity 2014
URL http://soundcloud.com/lshtm/tbtreatment
 
Description Packed Lunch 
Form Of Engagement Activity A broadcast e.g. TV/radio/film/podcast (other than news/press)
Part Of Official Scheme? No
Geographic Reach Local
Primary Audience Public/other audiences
Results and Impact invited talk at Wellcome Collection on measurement of mental health outcomes, as part of a series presented by locally based researchers. Made into a podcast
Year(s) Of Engagement Activity 2017
URL https://wellcomecollection.org/packed-lunch-podcast
 
Description Pint of Science 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach Regional
Primary Audience Public/other audiences
Results and Impact Talk about the ethics of spatial methods in public ealth. Presented to members of the public in a pub as a way of engaging them in our work.
Year(s) Of Engagement Activity 2017
URL https://pintofscience.co.uk/
 
Description Plenary HW 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Plenary given by Prof Helen Weiss at CROI 2018 : "Are we on track to "bend & end" the HIV epidemic?".
Year(s) Of Engagement Activity 2018
 
Description PopART Podcast (January 2014) 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Professional Practitioners
Results and Impact Introduced an alternative approach to controlling HIV in southern Africa - one that focuses on treatment rather than prevention.

None reported
Year(s) Of Engagement Activity 2014
URL http://www.scidev.net/global/hiv-aids/multimedia/hiv-treatment-as-prevention-in-africa.html
 
Description PopART Talk at IAS 2015 Conference, Vancouver 
Form Of Engagement Activity A talk or presentation
Part Of Official Scheme? No
Geographic Reach International
Primary Audience Policymakers/politicians
Results and Impact Presented PopART data on achievement of 90-90-90 UNAIDS targets to mixed group of policy-makers and scientists
Year(s) Of Engagement Activity 2015
 
Description PopART dissemination 
Form Of Engagement Activity A press release, press conference or response to a media enquiry/interview